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ABSTRACT
PURPOSE: The overall aim of this study was to examine the effects of a high-fructose diet on
postprandial lipemia and hormones associated with glucose control during periods of altered
physical activity. METHODS: Twenty-two recreationally active males and females participated
in this randomized, cross-over design study (age: 21.2 ± 0.6 years; BMI: 22.6 ± 0.6 kg/m2).
Subjects ingested 75 g of fructose for 14 days during a period of high physical activity
(FR+Active) (>12,500 steps/day) and a period of low physical activity (FR+Inactive) (<4500
steps/day). Prior to and following the 2 wk loading period, a fructose-rich meal challenge was
administered (45% carbohydrate [25% fructose], 40% fat, and 15% protein). Blood was sampled
at baseline and for 6 h after the meal and analyzed for triglycerides (TG), very-low density
lipoproteins (VLDL), c-reactive protein (CRP), tumor necrosis factor-α (TNF- α), interleukin-6
(IL-6), glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), cpeptide, glucose and insulin concentrations. Area under the curve (AUC) and absolute change
from peak to baseline concentrations (∆peak) were calculated to quantify the postprandial
responses. RESULTS: TG, VLDL and IL-6 significantly increased in response to the
FR+Inactive intervention (p<0.05), while GIP, insulin, c-peptide and GLP-1 (males only)
significantly decreased in response to the FR+Active intervention (p<0.05). No changes occurred
with glucose, TNF- α, and CRP concentrations for either intervention (p>0.05).
CONCLUSIONS: When an inactive lifestyle is adopted for two weeks, while consuming a high
fructose diet, postprandial lipidemia and low grade inflammation occurs. In contrast, two weeks
of increased physical activity induces positive changes in hormones associated with glucose
control in order to attenuate the deleterious effects of the fructose-rich diet.
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Introduction:
In the United States and worldwide, the prevalence of obesity is increasing, with
approximately 67% of the U.S. population over 20 years of age considered overweight (BMI
≥25kg/m2) or obese (BMI ≥ 30kg/m2) 1. Obesity contributes to metabolic abnormalities such as
insulin resistance, dyslipidemia, hypertension, and glucose intolerance, all of which are risk
factors associated with metabolic syndrome 2. Individuals with metabolic syndrome have
increased risk of type 2 diabetes as well as cardiovascular disease and vascular dysfunction 3.
The growing prevelance of metabolic syndrome seems to be an end result of our current lifestyle
which promotes high caloric, high fat foods and minimal physical activity resulting in a state of
positive energy balance 4. Lifestyle behaviors such as dietary and exercise habits are strongly
associated with risk for development of obesity and metabolic syndrome 5. Increased adiposity
and physical inactivity may represent the beginning of the appearance of these risk factors.
Understanding the metabolic and cardiovascular disturbances associated with diet and exercise
habits is a crucial step towards reducing the risk factors for metabolic syndrome.
With increased availability of palatable food, people tend to overconsume and thus
increase caloric intake well in excess of caloric expenditure 6. Palatability of foods may be
altered through an alteration of fat and sugar content. This natural attactiveness toward
sweetness is responsible for a substantial comsumption of sugars 7. These sugars may occur
natually or can be manufactured and include sucrose, fructose and glucose. The
monosaccharides glucose and fructose are present in small amounts in fruits and honey 6.
Sucrose, a disaccharide formed by one molecule of fructose and one molecule of glucose bonded
together with an α 1-4 glycoside bond, is found in sugar cane and beets. Fructose can also be
found in high fructose corn syrup (HFCS) which consist of a combination of fructose and
glucose, usually in a 55:45 ratio (55% fructose, 45% glucose)8. HFCS is a popular additive in
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processed food because its adds sweetness, being 100% sweeter than sucrose, enhances color and
texture, perserves the food, is a cheaper alternative to sucrose 6 and can improve sports
performance 9. HFCS is also a lower glycemic food than glucose, making it seem like a
beneficial alternative to glucose for diabetics. A consequence of the addition of HFCS to our
food suppy has resulted in the consumption of fructose to increase by 135% from 1977 to 2001,
paralleling the rising rate of obesity over that same time period 2,10. Today, the average
American consumes 60-70 g/day of HFCS alone 8,11; leading many researchers to believe that a
causitive link beween obesity and fructose consumption may exist.
There is a growing body of evidence in animal and human models that high dietary intake
of fructose is an important nutritional factor associated with development of insulin resistance 12,
fatty liver 13, elevated uric acid 14, hyperlipidemia 15, 16 and hypertension 17 and an increase in
small-dense low-densitiy lipoproteins18; all risk factors associated with metabolic syndrome.
Fructose overfeeding has also been linked to hepatic insulin resistance, reduced lipid oxidation
and increased triglyceride formation in healthy
19

males . Researchers therefore, postulate

Figure 1: Fructose absorption in enterocytes

Figure 1: Fructose transport into the enterocytes

that increased consumption of fructose may be
one environmental factor contributing to
the development of obesity and abnormalites
associated with metabolic syndrome 2.
The metabolic consequences of
chronic fructose consumption can be
attributed to the unique metabolism of fructose.

Breves et al Volume 109, Issues 1–3; pgs 4–
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When fructose is present in the gut, either as free fructose or from HFCS, it is transported freely
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into the enterocytes via GLUT 5 transporters whereas the transport of glucose requires ATP
hyrolysis and is sodium-dependent at the brush boarder of the intenstines 6 (Figure 1). Free
fructose is quantitatively limited to absorption rates ranging from 5-50 g. When fructose is
consumed with glucose however, as is the case with sucrose and/or HFCS, fructose abosprtion
rates are considerably higher 20, 21.
Following the absorption from the intestine, the fructose that is present in the hepatic
portal blood is rapidly taken up by the liver via GLUT 2 transporters. Glucose metabolism is
limited by glucokinase and, once phosphorylated, is regulated by the energy status of the cell via
phosphofructokinase, yet fructose does not have a rate-limiting enzyme in hepatic metabolism 19.
When large amounts of fructose are consumed, significant quantities of fructose enter the
glycolytic pathway distal to phosphofructokinase, faciliting a very-low densitiy lipoprotein
(VLDL) and triglyceride production in liver, resulting in de novo lipogenesis (DNL) 21. Hence,
the ability of

Figure 2: Fructose Metabolism in the Liver

fructose to stimulate
VLDL synthesis is
unregulated which
makes fructose a
highly lipogenic
macronutrient.
Given the
unique metabolism
of fructose,
consumption of

Basciano et al Nutr.Metab.(Lond), 2005, 2, 1, 5
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fructose results in increased postprandial triglyceride formation (Figure 2) 22. The elevated
release of TG from the liver after fructose feeding increases systemic VLDL-TG concentrations
which can enhance fat accumulation in adipocytes 6, 22. Excess adipose tissue accumulation
increases fatty acid flux to other tissues such as the muscle as well as various other peripheral
tissues 22.
Consequently, the hypertriglyceridaemia which can be induced by fructose feeding, is
associated with increased atherogenic small-dense low-density lipoproteins (sdLDL) 23. These
molecules have been shown to increase the atherogenic potential of the plasma and promote lowgrade inflammation 23. Furthermore, sdLDL particles become highly atherogenic when oxidized
due to the ability to up-regulate scavenger receptors on active monocytes, transforming them into
macrophages and eventually leading to foam cell formation 23. Foam cells are highly atherogenic
after modification. The ability of fructose to lead to low-grade inflammation may result in
endothelial dysfunction given that fructose has the ability to increase hepatic production of
VLDL’s and systemic sdLDL’s 8. Increased endogenous triglyceride-rich lipoproteins (TRL)
such as VLDL that are present with excessive fructose ingestion 2 as well as exogenous TG and
chylomicrons can cause an increase in neutrophil production with concomitant production of
pro-inflammatory cytokines and oxidative stress, all leading to endothelial dysfunction 23.
High fructose consumption has also been linked to hyperuricemia, an added risk factor
for endothelial dysfunction and metabolic syndrome. Fructose-induced hyperuricemia is a
consequence of fructose depleting ATP when it is metabolized from fructose to fructose 1phosphate resulting in phosphate depletion and stimulation of AMP deaminase. AMP-deaminase
eventually leads to uric acid formation through the xanthine oxidase pathway 8. Elevated uric
acid concentration inhibits endothelial nitric oxide synthase (eNOS), a stimulator of endothelial
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vasodilation 6, and the ensuing vasoconstriction can lead to hypertension and impaired glucose
uptake to skeletal muscles. Moreover, increased uric acid levels can increase oxidative stress,
increase pro-inflammatory markers and decreased adiponectin levels, all factors which can lead
to insulin resistance 24.
Although the increased consumption of fructose is a public health concern, finding
alternative interventions to help combat the side effects of this nutrient should become a public
health priority to combat the risks associated with fructose consumption. Physical activity has
been demonstrated as an effective alternative treatment for metabolic syndrome and dyslipidemia
4

. Both high density lipoproteins (HDL) and serum TG favorably respond to changes in habitual

physical activity such that HDL increase and serum TG levels decrease relative to the volume of
exercise and/or intensity 25. Moreover, physical activity alters the metabolic makeup of an
individual by increasing hepatic lipid oxidation, increasing skeletal muscle lipoprotein lipase
(LPL) activiy and promoting clearance of TG 4. Physical activity also increases mitochondial
density, improving oxidation rates of long and medium chained fatty acids, reduces ceramide
production and hence increasing insulin sensitivity and modulating hepatic lipase activity
thereby reducing triglyceride-rich reminant proteins 26. All of these responses impact
postpranidal lipemia and atherogenic dyslipidemia. Hence, increased physical activity may be a
viable option to counteract the deleterious effects of a diet high in fructose, particulary in
individuals considered to be sedentary.
Regulary physical activity has been shown to improve postprandial TG clearance due to
enhanced fat oxidation, elevated LPL response and increased energy expenditure 27. The
exercise-induced attenuation of postprandial TG is also partly mediated by a reduction in hepatic
TG synthesis and VLD-TG secretion 28. Hence, the combined effect of regular physical activity
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and fructose ingestion are of interest since high physical activity may protect against fructose
ingestion and low physical activity may exacerbate the effects of fructose. Consequently,
increased physical activity may be a viable lifestyle change to minimze the susceptibility to
fructose-induced hyperlipidemia and systemic low-grade inflammation.
There is limited research regarding physical activity and chronic fructose consumption,
although the effects of physical activity on postprandial lipemia are well known 27, 28, 30.
Previous research regarding exercise and fructose consumption has been aimed at determining
the efficiency of fructose in improving athletic performance 29, however the average Amercian
who is consuming fructose may not be participating in regular, high intensity exercise.
Additionally, these studies examinded the importance of fructose ingestion during exercise and
have not focused on the ramifications of a high fructose diet combined with low physical activity
on a persons overall health.
Although considerable research has been conducted linking HFCS to the increased
prevalence of obesity and metabolic syndrome risk factors, these studies have mainly been
performed on animals 31, 32, and/or in post-absorptive state 33. Additionally, numerous studies
are not without controversy; such as the specific dose of fructose used, which can significantly
alter the outcome of such studies 34. Further, the magnitude of the effect of fructose may depend
on other aspects of the diet, including the total amount of carbohydrates and fats in the diet and
the overall consumption of the meal. Therefore, the overall aim of this study was to examine the
effects of a diet high in fructose on postprandial lipidemia, inflammatory markers and glucose
tolerance in a young, healthy population and to investigate whether increased physical activity
alters such effects.

7
Specific Aims:
1. To investigate if an increase in fructose consumption over a two week period increased
postprandial lipemia and whether increased physical activity (>12,500 steps) altered this
response. Hypothesis: We hypothesized that a diet rich in fructose increased postprandial
lipidemia and increased physical activity attenuated these increases as compared to a
sedentary lifestyle in a healthy, young population.

2. To determine whether chronic fructose consumption increases inflammatory markers
associated with low-grade inflammation and whether increased physical activity alters
such a response. Hypothesis: We hypothesized that a high fructose diet over a 2-wk
period increased pro-inflammatory markers induced by the elevated lipid production and
these effects were be ameliorated with high physical activity.

3. To determine whether chronic fructose ingestion alters glucose tolerance and insulin
resistance and to elucidate whether increased physical activity alters such responses.
Hypothesis: We speculated that chronic fructose consumption induced hyperglycemia
and hyperinsulinemia which would be minimized with increased physical activity.
Limitations:
1. Subjects were participating in an ad libitum diet therefore dietary habits were not altered
during the intervention period. Although subjects were instructed not to consume any
additional sugar aside from their normal dietary consumption, this may pose a problem
when substantiating the results as a direct effect of the added HFCS consumption and not
other aspects of their diet. To limit such effects, the subjects completed a three-day
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dietary log prior at the start of the study and 24-hour food recall periodically throughout
the intervention to evaluate their normal dietary habits.

2. There was no way to determine whether the subjects consumed all the HFCS beverage
given. To minimize this problem, the subjects were instructed to return their empty
bottles to the lab once per week to help ensure subject compliance.

Delimitations:
1. The study was limited to only healthy, normal weight individuals, thus extending the
results to other populations (e.g. individuals with type 2 diabetes) would need to be done
with caution.
2. Subjects over the age of 35 were not included to minimize potential differences in
hormonal levels that may occur with pre-menopause and the potential effect on fat
metabolism. This resulted in a more homogenous age of subjects.
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Chapter II:
Review of Literature
Introduction:
The prevalence of obesity and obesity-related diseases in the United State and
worldwide is increasing rapidly 2. More than half of the US population is considered to
be overweight with nearly one-fourth being clinically obese 35. Moderate obesity can
contribute to chronic metabolic abnormalities characteristic of metabolic syndrome which
include insulin resistance, dyslipidemia and hypertension 2. Increased fructose
consumption has paralleled the increased prevalence of metabolic abnormalities and may
be a contributing factor to the rise in such disease-related risk factors 2.
The addition of fructose in the food supply became popular in the 1970’s when
fructose was used to produce high fructose corn syrup (HFCS). HFCS can contain up to
90% fructose, however, most of the HFCS that is commercially sold contains 55%
fructose and 45% glucose and is produced by the enzymatic isomerization of dextrose to
fructose 2. HFCS is frequently used as a sweetener in the food industry because it is
cheaper to produce, has a long shelf-life, maintains a long-lasting moisterization in
industrial bakeries and is sweeter than most other sugars 36. The use of fructose became
even more abundant when individuals with type 2 diabetes began replacing glucose with
fructose due to the ability of fructose to attenuate the acute increase in insulin levels,
therefore being touted as a low-glycemic alternative to glucose for these individuals 36.
In recent years, there has been an increased interest in the potential role of dietary
fructose as a contributing factor to metabolic syndrome. When consumed in elevated
concentrations, fructose can promote metabolic changes that may contribute to risk
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factors associated with metabolic syndrome as well as hyperuricemia, inflammation and
alterations in various metabolic hormones 35.
The following review of literature will present evidence that fructose may cause
substantial alterations in the risk factors associated with metabolic syndrome. The first
section of the review will discuss fructose metabolism and the link between fructose and
hyperlipidemia, insulin resistance, glucose intolerance, hypertension and hyperuricemia
followed by inflammation and effect of incretin hormones on fructose ingestion. Lastly,
section four will discuss the benefits of physical activity and how increasing physical
activity may counteract various risk factors associated with fructose consumption.
I.

Fructose:
a. Fructose Absorption and Metabolism:
Fructose enters the brush border of the stomach in the form of either pure fructose,
high fructose corn syrup (HFCS) or as sucrose, a disaccharide comprised of 50% fructose
and 50% glucose 6. When fructose is ingested as a disaccharide in the form of sucrose,
the sucrose must first be cleaved into one molecule of glucose and one molecule of
fructose before being metabolized. Sucrase, an enzyme located in the brush boarder of
the small intestine enterocytes is responsible for this reaction. Fructose is then absorbed
and transported through the enterocytes to the portal bloodstream by a fructose-specific
hexose transporter, glucose transporter GLUT 5. Unlike glucose, the activation of GLUT
5 transporters is sodium–independent and does not require ATP hydrolysis 6. Once inside
the enterocytes, fructose diffuses across the basolateral pole of the enterocytes and into
the portal circulation via GLUT 2 transporters 37.
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Unlike glucose, fructose is incompletely absorbed in the enterocytes. The absorption
capacity of fructose is limited to approximately 5-50 grams at one time before some
individuals suffer from symptoms of diarrhea and flatulence 38. Ushijima et al 39 showed
that 80% of healthy adults experienced incomplete absorption when given 50 grams of
fructose yet when fructose is consumed with glucose, the rate of absorption is increased
40

. Thus, when fructose is consumed as sucrose or as HFCS (glucose and fructose

combined), more fructose is absorbed through the enterocytes. The improved absorption
of fructose in conjunction with glucose may be due to the up-regulation of GLUT 5
receptors which is stimulated by elevated glucose absorption 38.
Once within the enterocytes, fructose can be easily converted to triglycerides. This
was evident in a study by Haidari et al 41 where they demonstrated that intestinal
triglycerides, in the form of chylomicrons, were increased in hamsters after a three-week
chronic fructose diet 41. Haidari et al 41 indicated that chronic, not acute fructose feeding
was associated with changes such as greater stability of intracellular apoprotein-B48
(apoB-48) and enhanced intestinal enterocyte de novo lipogenesis 41. The intestinal
overproduction of apoB-48 containing lipoproteins may be an important contributor to
the elevation of circulating TG-rich lipoproteins which may potentially lead to
atherosclerosis 41.
Although fructose can be lipogenic within the enterocytes, fructose is also readily
absorbed and stimulates lipogenesis within the hepatocytes 6. Once fructose travels
through the enterocytes and into the portal vein, it is readily absorbed by the liver via
GLUT 2 transporters. Due to the high concentration of GLUT 2 transporters and
fructokinase, there is a high affinity for fructose uptake in the liver 6. Once within the
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liver, fructose is rapidly converted to fructose-1-phospate via fructokinase. Fructokinase
has a low affinity for fructose, resulting in rapid metabolism of fructose by the liver cells.
Fructose is further metabolized into triose phosphates, glyceraldehyde and
dihydroxyacetone phosphate 20. The triose phosphate that is produced can then be
converted to pyruvate and oxidized into carbon dioxide and water in the citric acid cycle
or a portion of the triose phosphate can be converted to lactate and released into the
systemic circulation 6. A portion of the carbon derived from the triose phosphates can
also enter the gluconeogenic pathway where it can be stored as glycogen to be later
released as glucose 20. This gluconeogenic process results in a small, but measurable
increase in systemic glucose concentrations 6.
Within the liver, fructose metabolism differs substantially from glucose metabolism
in that entry of glucose into the glycolytic pathway is under the control of glucokinase
which has a low affinity for glucose within the hepatocytes and is dependent on the
concentration of glucose. Therefore the rate of glucose phosphorylation varies with
changes in glucose concentrations 6. Moreover, downstream, when fructose-6-phosphate
is converted to fructose 1,6-bisphosphate, this reaction is catalyzed by
phosphfructokinase (PFK), an enzyme regulated by the energy status of the cell. In
particular, PFK is inhibited by elevations in ATP and citrate. This inhibition allows for a
close regulation of glycolysis based on the energy status of the cell 20. On the contrary,
fructose is phosphorylated to fructose-1-phoshpate by fructokinase, but this rate-limiting
enzyme does not have the tight regulation as seen with PFK 36. Figure 3 depicts these
proposed mechanisms underlying the aforementioned differential effects of fructose
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compared to glucose consumption on postprandial lipid metabolism and glucose
tolerance/insulin sensitivity 42.
Figure 3: Metabolic Differences Between Fructose and Glucose

Figure 3: Fructose metabolism differs from glucose (black arrows) due to 1) a nearly complete hepatic
extraction and 2) different enzyme and reactions for its initial metabolic steps. Fructose taken up by the
liver can be oxidized to CO2 and then converted into lactate and glucose; glucose and lactate are
subsequently either released into the circulation for extrahepatic metabolism or converted into hepatic
glycogen or fat. The massive uptake and phosphorylation of fructose in the liver can lead to a large
degradation of ATP to AMP and uric acid (Havel, Nutrition Reviews, Vol. 63, No. 5)

b. Fructose-induced Lipogenesis:
The most detrimental aspect of fructose is its ability to be converted to fatty acids
within the hepatocytes via DNL, as pictured in figure 3 6. In rodents, a high-fructose diet
(60% fructose) has been shown to increase intra-hepatocellular lipids as well as stimulate
hepatic DNL within a few days 43. When such diets are sustained over a prolonged period
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of time, high fructose or sucrose diets will induce hepatic stenosis and whole-body
insulin resistance with a concomitant accumulation of intramyocellular lipids 44.
Fructose serves as a preferential source for hepatic lipogenesis. Relative to
glucose, the extraction and metabolism of fructose in the liver are exceptionally high due
to the extensive amount of fructokinase present in the liver whereas glucose uptake in the
liver is specifically dependent on glucokinase 6. Glucokinase has a relatively low affinity
for glucose, resulting in lower concentrations of glucose being absorbed in the liver.
Once glucose is converted to glucose-6 phosphate, phosphofructokinase (PFK) regulates
the fate of glucose, whether it is stored as glycogen of catabolized for energy 6. On the
contrary, the subsequent metabolism of fructose to fructose 1-phosphate at the triose
phosphate level bypasses control at PKF 45. When large amounts of fructose are
consumed, significant quantities of carbon from fructose continues to enter the glycolytic
pathway distal of PFK at the level of the triose phosphate (dihydroxyacetone phosphate
and glyceraldehydes-3-phosphates), causing an increased production of TG and VLDL
production in the liver 20. Once the glycolytic pathway becomes saturated with fructose
intermediates, the intermediates can be converted to glycerol-3-phosphate which provides
the glycerol moiety of triglyceride synthesis. These intermediates can also be further
metabolized to pyruvate, which is then converted to acetyl-CoA. When acetyl-CoA
combines with oxaloacetate to form citrate in the mitochondria, the carbon atoms can be
used for de novo lipogenesis and then form long-chained fatty acids that are eventually
esterified into triglycerides 20. This large source of unregulated TG formation is unlike
that of glucose metabolism which has a rate-limiting step to regulate it, preventing such
effects.
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To date there is an abundance of research indicating that acute and/or chronic
ingestion of fructose causes hyperlipidemia in rats 43, 46, 47 and in humans 48-51. Faeh et al
51

examined whether short-term fructose consumption results in hypertriglyceridemia.

The investigators measured fasting de novo lipogenesis in seven healthy men who were
given 3 grams of fructose/kg of body weight/per day for 6 days 51. At the beginning and
end of the study period, the subjects participated in a 13-h metabolic testing day in which
hepatic de novo lipogenesis was measured. After the six days of fructose loading,
subjects’ plasma triglyceride concentrations increased by 79% from baseline values.
Moreover, fractional de novo lipogenesis increased six-fold over the six-day period when
compared to baseline and was speculated to contribute to the observed
hypertriglyceridemia 51. Caution needs to be taken however, as the fructose load that was
given (210 g/day) was an extremely high load and therefore may not be clinically
relevant.
Using a more clinically relevant fructose load, Swanson et al 52 studied 14 healthy
male and female subjects on a diet containing 20% of energy from fructose verses an
isocaloric starch diet to determine if fructose leads to metabolic disturbances. After
twenty-eight days on the high fructose diet, serum total and low-density lipoprotein
(LDL) cholesterol levels were 9% and 11% higher, respectively, than the starch diet,
resulting in a significant difference between the fructose-only groups and the starch
groups (p<0.05) 52. Furthermore the authors observed a transient and significant increase
in serum triglyceride levels in the fructose-fed group after day one of the intervention.
The fructose-fed subjects’ triglycerides levels increased by1.68 mmol/L above baseline
whereas with the starch diet, triglyceride levels increased by 1.31 mmol/L 52. Hence, it
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was concluded that fructose induced hyperlipidemia within 28 days on a high fructose
diet and such alterations occur in as little as 24 hours after the first fructose load.
In a slightly longer intervention, Bantle et al 54 compared the effects of a diet
consisting of either 17% of energy from fructose or 17% glucose for six weeks on 24
adult subjects (12 males/ 12 females). During this randomized, balanced crossover
design, subjects underwent a 24 h metabolic profile over a 24 h period on days 7, 14, 21,
28, 35 and 42. The only day in which mean fasting plasma TG concentrations did not
significantly increase above that of the glucose diet levels was at 21 days in the male
subjects only. Additionally, the plasma TG area under the curve (AUC) on day 42 was
32% greater than on the glucose diet in the male subjects, suggesting that the fructose,
per se, was associated with elevations in fasting and postprandial TG concentrations 54.
The fructose diet had no significant effect on fasting or postprandial plasma
triacylglycerol concentrations in women.
More recently, Swarbrick et al 48 investigated the metabolic effects of a highfructose diet in seven overweight, post-menopausal women while the subjects resided in
a supervised setting and consumed standardized, energy-balanced meals for 14 weeks.
During the first 4 weeks, the women were instructed to participate in a weightmaintaining, complex carbohydrate diet which was then followed by ten weeks of an isocaloric, high fructose diet in which subjects consumed a fructose-rich (25% of calories
from fructose) drink with each meal 48. At weeks two and ten of the fructose
intervention, subjects had blood samples drawn from 0800 to 2200 h, at 30 min intervals,
around meal ingestion. After week two on the diet, TG AUC was unchanged however
after week ten, triglyceride AUC values were 141% higher than at baseline. Circulating
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TG levels increased more than 1 mmol/L over fasting concentrations for the entire period
from lunch until 2200h in the evening. Additionally, fasting apoB concentrations were
increased by 19% compared to baseline. The authors speculated that the increases in
fasting and postprandial TG concentrations were most likely due to stimulation of TG
synthesis 48.
Although the research regarding fructose ingestion and fasting and postprandial
lipogenesis is apparent in normal weight individuals, research is more limited in the
obese population. Stanhope et al 49 investigated whether similar results occurred in
overweight/obese population (BMI= 25-35kg/m2). The investigators studied 18 postmenopausal women for 12 weeks. For the first two weeks the subjects resided on an inpatient hospital unit where they consumed an energy balanced diet. The next eight weeks
was an outpatient intervention in which the subjects consumed either a fructose- or
glucose- rich beverage containing 25% daily energy while eating an ad libitum diet. This
was then followed by an additional two weeks in the in-patient facility. During the
second inpatient phase, subjects continued to consume their fructose or glucose drink but
also maintained an energy balanced diet, instead of the ad libitum diet 49. The excess
fructose intake (~25% of energy requirements) for 10 weeks significantly increased
fasting and 24h postrpandial triglycerides when compared with the glucose drink of equal
caloric content 49. Post-intervention, there was a significant increase in fasting apoB
(27.2%), LDL (13.9%), small-dense LDL (44%), and oxidized LDL (12%) in the fructose
group compared to the glucose group. This study reitorates the fact that long-term
consumption of fructose of ≥2 weeks negatively alters lipid remodeling in obese, postmenapausal woman 49. Stanhope et al 49 stated that the mechanism by which fructose
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induced lipemia is a result of the carbon atoms from fructose being converted to fatty
acids, skipping the rate-limiting step in glycolysis. As stated previously, fructose
increases DNL by increasing hepatic TG formation, however, Stanhope et al 49 also
speculated that the fructose-induced hepatic DNL may limit fatty acid oxidation as well.
Fructose increases acetyl-CoA concentrations in the liver, subsequently leading to
increased production of malonyl CoA which inhibits the entry of fatty acids into the
mitochondria 36. Taken together, fructose indirectly inhibits fatty acid oxidation by
increasing production of malonyl CoA which decreases fatty acid transport into the
mitochondria 55. Malonyl CoA is an important intermediate to fructose-induced
lipogenesis because acetyl CoA is added to long-chained fatty acids via malonyl CoA.
therefore allowing fructose to provide carbon atoms for both glycerol and the acyl portion
of the acylglycerol molecule 36.
To better understand the hypothesis of Stanhope et al 49 that fructose
ingestion may also inhibit fat oxidation, Abdel-Sayed et al 19 investigated whether
a high-fructose diet (234 g) with an excess energy intake of about 3640 kJ/d (67%
carbohydrate, 22% fat and 11% protein) compared to a control diet (55% carbohydrates,
30% fat and 15% protein) impaired lipid metabolism in six healthy males within a
seven-day period. Plasma non-esterified fatty acids (NEFA), plasma TG, plasma βhydroxybutyrate (synthesized from acetyl CoA), lipid oxidation and exogenous lipid
oxidation in a basal state, after a lipid infusion as well as during and after a
standardized mental stress procedure on days 1 and 7 of the intervention were measured.
After seven days on the high fructose diet, basal NEFA concentrations significantly
decreased by 19.5%, net lipid oxidation by 21.3% and plasma β-hydroxybutyrate
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concentrations by 78.2%. After the lipid loading, the increase in net lipid oxidation and
exogenous lipid oxidation were comparable between the control diet and the fructose
diet however, after the mental stress, there was a markedly blunted stimulation of plasma
NEFA and β-hydroxybutyrate release in the fructose group after seven days. The lower
basal plasma NEFA concentrations indicated that an inhibition of adipose tissue lipolysis
occurred after the high fructose diet 19. Under those conditions, Abdel-Sayed et al 19
speculated that the decreased NEFA seen with the high-fructose diet was likely related to
fructose-induced stimulation of hepatic de novo lipogenesis and not secondary to an
increased hepatic re-esterification. Additionally, the inhibition of lipolysis may, in turn,
be directly responsible for lower whole-body net lipid oxidation following fructose
loading since NEFA concentrations are the main determinant in this process 19.

c.

Fructose and Postprandial Lipemia
Although research regarding fasting hyperlipidemia and fructose consumption has

been well established, high postprandial triglyceride levels have been associated with the
risk of coronary artery disease 56. Hence there is growing evidence linking increased
postprandial TG concentrations with a pro-atherogenic state 56. This link may be due to
lipoprotein remodeling induced by increased levels of VLDL’s and mediated by
cholesteryl ester transfer protein (CETP) and hepatic lipase. Both increased VLDL’s and
CEPT resulted in increased concentrations of small-dense lipoproteins and remnant-like
lipoproteins 56.
When in the blood, triglycerides can be referred to as “triglyceride-rich
lipoproteins” (TRL’s) and consist of two main components: VLDL and chylomicrons.
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Very low-density lipoproteins are a result of hepatic synthesis and chylomicrons are
produced by the gut postprandially in order to transport dietary lipids from the intestines
to other locations in the body 56. Therefore, TRL can be produced exogenously from the
diet or endogenously from the liver. Chylomicrons and VLDL’s can then form
intermediate-density lipoproteins catalyzed by lipoprotein lipase (LPL), an enzyme
released from the capillary beds of adipose tissue and skeletal muscle 56. Lipoprotein
lipase, situated in the capillary endothelial, is responsible for hydrolyzing the TG into
NEFA23. This pathway is up-regulated by insulin, which increases rapidly in response to
a carbohydrate meal. In a fructose-rich diet, reduced insulin concentrations may
contribute to lower postprandial LPL activity 49. The previously mentioned study by
Stanhope et al 49 stated the importance of LPL on postprandial lipemia. They observed
that there was a significantly greater postprandial LPL response in the glucose group than
the fructose group, suggesting that reduced TG clearance might also contribute to the
fructose-induced postprandial hypertriglyceridemia that was evident in their study 49.
Chong et al 57 also observed a lower insulin excursion after a fructose load was
given to 14 healthy subjects. In this study, subjects were given a fructose drink (.75 g/kg
of BW) on one occasion and a glucose drink (.75 g/kg of BW) on another with an isotope
tracer (250 mg D-[U13C]fructose or D-[U13C] glucose) and then measured for 6 hours to
determine the fate of the carbohydrate. The fructose, not glucose drink led to an
attenuated LPL response which potentiated postprandial lipidemia as the TG-VLDL and
TG-rich chylomicron levels were significantly higher than the glucose group 57. The
lower insulin concentrations seen with fructose load led to a decreased production of
LPL, resulting in impaired triacylglycerol clearance 57.
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In the adipose tissue, some fatty acids released by LPL are directed into fat
storage and others are released into circulation 57. Lipoprotein lipase is known to be
activated by insulin. In the study by Chong at el 57, fructose did not stimulate insulin to
the same extent as glucose and therefore NEFA levels were lower 57. As a result of their
findings, the researchers suggested that the lower postprandial NEFA concentrations in
the plasma in the fructose condition were most likely due to a smaller spillover of LPLderived fatty acids from the chylomicron-TG 57.
To determine the postprandial effect of a fructose load after a breakfast and a
subsequent lunch, Parks et al 50 investigated the magnitude of an acute load of fructose on
lipogenesis. This two-test meal day represents a more typical Western diet in which a
person eats every 4-6 hours. They examined the magnitude of lipogenesis after an acute
bolus of fructose in the morning and after a subsequent meal. The six healthy adults were
given a carbohydrate meal which consisted of either 100% glucose, 50% glucose:50%
fructose or 25% glucose:75% fructose for breakfast followed by a standardized lunch
four hours later. After the morning bolus, fractional lipogenesis was stimulated and
peaked at 15.9% when the 50% fructose meal was given and at 16.9% when the 75%
fructose diet was given. Both of these fructose loads were significantly higher than the
glucose only group which only increased by 7.8% above baseline 50. Post lunch, the TG
incremental AUC for 50:50 and 25:75 were significantly higher than the 100:0 bolus,
although not significantly different from each other. Over the course of the study day,
both fructose doses resulted in significantly higher TG incremental AUC when compared
to the glucose only meal. This data implies that fructose acutely and significantly
increased lipogenesis (measured by infusion of 13C1-acetate and analysis by GC-MS),
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which elevated TG concentrations in the morning but also contributed to greater TG
concentrations after lunch. Hence, the fructose-induced increase in lipogenesis displaced
the use of stored TG for VLDL synthesis and that the stimulation of lipogenesis
represents an intracellular signal for liver to esterify fatty acids from any source into TG
50

. These authors concluded that there is an immediate lipogenic effect of fructose in

healthy, lean subjects in the morning and after a subsequent meal, suggesting that when
fructose is consumed in the fasted state, the subsequent postprandial lipidemia is
augmented.
In the previously mentioned Stanhope et al 49 study, postprandial fractional de
novo lipogenesis after subsequent meals was also measured. Prior to and after a 10-week
intervention period of either high fructose (25% energy from fructose) or a high glucose
intervention (25% from starch) the obese subjects reported to the lab for a metabolic test
day. During the test day, they ingested a buffet meal ad libitum at breakfast, lunch and
dinner along with their specific intervention drink. Their results indicated that during a
period of steady-state feeding in which subjects were given a meal every four hours
during a 12-hour period, an 11.4% increase in de novo lipogenesis above fasting values
occurred. These values increased to 75.4% when the same metabolic test day was
repeated 10 weeks after a fructose-rich meal. In contrast, the glucose intervention group
had an increase in de novo lipogenesis during their first metabolic test day of 13.4%.
This value increased to 27.3% after the 10-week intervention. The researchers stated that
both increased de novo lipogenesis and decreased lipoprotein lipase-mediated clearance
contributed to fructose-induced postprandial hypertriglyceridemia 49.
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Based on the previous review of literature, the following can be concluded: 1) the
liver is the main site of fructose metabolism, 2) fructose bypasses the main rate limiting
step of glycolysis, thus providing unregulated amounts of lipogenic substrates such as
acetyl-CoA and glycerol-3-phosphate and 3) fructose enhanced de novo lipogenesis when
subsequent meals were ingested. Thus, these factors by which fructose promote
lipogenesis are likely to include multiple mechanisms.

d. Fructose and Insulin Resistance:
Type 2 diabetes is a progressive disorder that begins with the development of
insulin resistance and potentially ends with pancreatic β-cell failure 58. A dietary
recommendation often proposed for patients suffering from type 2 diabetes is to ingest
foods that do not cause an acute rise in insulin levels, therefore preventing overstimulation of insulin secretion from the pancreas. Initially fructose was a popular
macronutrient choice for individuals with type 2 diabetes because fructose does not cause
an acute rise in insulin due to the low glycemic index related to fructose. Contrary to no
acute rise in insulin, fructose consumption is related to an increase in hepatic VLDL
triglyceride secretion, and possibly decreased extra-hepatic clearance of VLDL-TG, both
of which are associated with the development of hepatic and adipose tissue insulin
resistance.
The VLDL-TG formed from fructose-induced hepatic DNL can be released into
the systemic circulation, consequently leading to an increase in the levels of fatty acids in
the circulation. Signaling abnormalities in adipocytes can also trigger lipolysis of TG
stores and efflux of NEFA into the bloodstream, augmenting the problem 60. NEFA in
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the bloodstream as a result of increased fructose-induced lipidemia may be a key
mechanistic link between fructose consumption and insulin resistance, type 2 diabetes
and metabolic dyslipidemia. These conditions are a result of increased ectopic storage of
NEFA by non-adipose tissues such as liver and skeletal muscle where they are stored as
TG or diacylglycerol. The exposure of these organs to increased concentrations of NEFA
from fructose ingestion may reduce insulin sensitivity by increasing the intramyocellular
lipid content 61. Once stored as ectopic lipids, the fatty acids can interfere with the
metabolic pathways of that tissue, resulting in fructose-induced insulin resistance 60.
In a healthy adult, insulin suppresses hepatic gluconeogenesis and glycogenolysis,
however, in the insulin resistant state, this suppression no longer occurs, causing a
subsequent increase in glucose output from the liver 58. Insulin resistance in fat cells
reduces the normal effects of insulin on lipids and results in reduced uptake of circulating
lipids and increased hydrolysis of stored triglycerides. Increased mobilization of stored
lipids in these cells elevates free fatty acids in the blood plasma, leading to reduced
muscle glucose uptake, and increased liver glucose production, all of which contribute to
elevated blood glucose levels 62. This chronic state of excess fatty acid release into the
circulation can induce lipotoxicity, or pancreatic β-cell death. To compensate for the
increased peripheral insulin resistance, the pancreatic β-cells increase in mass and secrete
more insulin resulting in hyperinsulinemia. Since the β-cells cannot compensate for the
resistant state, hyperglycemia occurs. Hyperglycemia further damages the β-cells
resulting in glycotoxicity, leading to a progressive loss of the pancreatic islet β-cells
manifesting into type 2 diabetes 58.

25
The molecular mechanisms underlying fructose-induced insulin resistance are not
completely understood but may be similar to that of a high-fat diet. Both high-fructose
and high-fat diets interfere with insulin signaling at common steps in skeletal muscle 63.
In liver cells, both high fructose and high-fat diets elicit hepatic stress responses and
activation of pro-inflammatory cascades that lead to insulin resistance. Sucrose-fed rats
demonstrate an early alteration of hepatic VLDL-TG secretion, leading to impaired
insulin-mediated suppression of glucose production in hepatic tissues after 1-2 weeks, but
show no changes in extra-hepatic insulin sensitivity after this time period 64. After 4-6
weeks, impaired extra-hepatic insulin sensitivity, in conjunction with muscle lipids
occurs 64.
Morino et al 65 suggested that the mechanism by which interacellular lipid causes
insulin resistance in both liver and muscle is through diacylclycerol (DAG)-induced
activation of novel protein kinase C (nPKC) 65. DAG is a known activator of nPKC, and
both DAG and nPKC are associated with lipid-induced insulin resistance in humans 65.
Activation of nPKC causes a decrease in insulin receptors or insulin receptor substrate 1
(IRS1) tyrosine phosphorylation 63. This IRS-1 inhibition decreases insulin-stimulated
glucose transporters (GLUT 4) activity resulting in reduced glucose uptake into the cell
66

. Increases in DAG also activate several other serine/threonine kinases such as

inhibitory kβ kinase β (IKKβ) and nuclear factor kB (NF- kB) which are also activated by
inflammatory markers such as tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6)
which are both known to down-regulate IRS-1 phosphorylation 66. This is in contrast to a
healthy cell in which case insulin binds to its receptor, and causes auto-phosphorylation
of the receptors. The phosphorylated receptor then phosphorylates the insulin receptor
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substrate proteins (IRS) on the tyrosine residues. The phosphorylated IRS recruits a
variety of second messenger proteins, initiating a complex signaling cascade which
involves Akt/PKB stimulation of glucose uptake into the cell. Insulin sensitivity is thus
maintained as a result of enhanced glycogen synthesis, suppression of hepatic
gluconeogenesis, increased fatty acid and triglyceride synthesis and suppression of
lipolysis in adipose tissue 67.
Cortright et al 68 found in isolated human skeletal muscles strips and adipocytes
that activation of PKC reduced insulin-stimulated glucose uptake; whereas,
pharmacological inhibition of PKC activity increased insulin-stimulated glucose uptake
by twofold. This increase was associated with elevated insulin receptor tyrosine
phosphorylation of PI 3-kinase activity. Hence, inappropriate activation of PKC may
interfere with insulin action by promoting serine/threonine phosphorylation of IRS-1
resulting in prevention of tyrosine phosphorylation of these proteins that is necessary for
adequate function on the insulin-signaling pathway 68.
Human research investigating the effects of fructose on insulin sensitivity is
limited but the animal literature is more extensive. Thorburn et al 69 fed rats a diet
containing 35% of energy as fructose for four weeks and found reduced insulin
sensitivity associated with impaired hepatic insulin action and whole-body glucose
disposal. This study demonstrated that although fructose does not increase insulin
acutely, the long-term consumption of fructose results in insulin resistance 2. Moreover,
Blakely et al 70 showed that fasting serum insulin and glucose concentrations were
significantly increased in rats that consumed 15% of energy from fructose for 15 months
compared to corn-starch 70. These results were in conjunction with a more recent animal
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study in which mice were fed an isocaloric, standard diet; a 60% glucose diet; or a 60%
fructose diet for twelve weeks. Glucose disposal was reduced in the fructose fed animals
compared to the other two groups 71. Moreover, the fructose-fed mice exhibited a 1.3
fold lower glucose-stimulated increase in insulin. From these results, it was suggested
that a high-fructose diet results in reduced glucose-stimulated insulin release in
comparison to a standard diet and impaired glucose disposal 71.
In humans, there is limited research confirming the negative effects of fructose on
insulin sensitivity and glucose intolerance in adults and adolescents. In a short-term study
Sunehag et al 72 studied obese adolescents to determine the metabolic effects of dietary
fructose on insulin sensitivity, insulin secretion and glucose tolerance 72. When six male
and female adolescents were put on either a high fructose diet (24% of total energy
intake) for seven days or a low-fructose diet (6% of energy intake) there was no change
in insulin sensitivity or secretion as well as no change in glucose kinetics, as assessed by
the stable labeled intravenous glucose tolerance test 72. In addition to having a very small
sample size, this study was confounded as the obese adolescents were insulin resistant
initially. In order to maintain substrate homeostasis, normal rates of glucose production,
gluconeogenesis, lipolysis and appropriate substrate oxidation, the obese subjects’
required more than twofold increase in their insulin secretion as compared what would
have been needed if lean adolescences were studied 72. Similarly, Le et al 44 found that
moderate fructose (1.5g/kg of body weight) intake for four weeks in seven male subjects
induced significant increases in plasma TG, and VLDL-TG with no change in insulin
sensitivity or ectopic fat deposition. The authors speculated that the duration of fructose

28
consumption may need to be longer than 4 weeks in order for the increases in plasma TG
and VLDL-TG to affect insulin sensitivity 44.
In contrast, Dirlewanger et al 18 investigated the effects of an acute fructose
infusion on hepatic insulin sensitivity during moderate hyperglycemic conditions in ten
healthy adults. These researchers monitored the plasma insulin concentrations required to
maintain euglycemia at 8 mmol/l during somatostatin and low physiological glucagon
infusions with or without fructose infusions. Subjects underwent three different
protocols: 1) hyperglycemic pancreatic clamp without fructose infusion; 2)
hyperglycemic pancreatic clamp with fructose infusion (16.7 µmol·kg-1·min-1) and 3)
hyperglycemia-hyperinsulinemic clamp. Glucose rate of disappearance, net endogenous
glucose production, total glucose output, and glucose cycling were measured with [6,6(2)

H(2)]- and [2-(2)H(1)]glucose. Hepatic glycogen synthesis was estimated from uridine

diphosphoglucose kinetics as assessed with [1-(13)C]galactose and acetaminophen. The
infusion with fructose resulted in alterations in endogenous glucose production such that
insulin requirements increased 2.3 fold above the two other infusions in order to maintain
blood glucose levels 18. The increased total glucose output indicated that the absolute rate
of glucose-6-phosphate hydrolysis and release of free glucose from the liver cells was
increased during fructose infusion. Simultaneously, glucose cycling was increased,
indicating enhanced reuptake and phosphorylation of glucose by the liver cells 18.
Therefore, an acute fructose infusion induces both extrahepatic and hepatic insulin
resistance, with the latter being secondary to an increased intrahepatic glucose 6phosphate synthesis 18.
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In a longer-term, previously mentioned study, Stanhope et al 49 proposed that the
increased hepatic lipid accumulation resulting from fructose-induced DNL would lead to
hepatic insulin resistance by increasing levels of DAG. Increases in both DAG and novel
PKC are associated with lipid-induced insulin resistance 49. After assessing insulin
sensitivity with deuterated glucose disposal prior to and after the 10-week intervention,
the fructose group had significantly higher fasting insulin and glucose levels as well as
increased insulin excursions and endogenous glucose production as compared to the
glucose group. Additionally, DNL was significantly higher in the fructose-fed group than
the glucose-fed group after the 10-week intervention. These results indicated that hepatic
insulin resistance was most likely due to increased DNL from increased DAG and novel
PKC 49.
Fructose over-feeding, regardless of total energy intake, exposes the liver to large
carbohydrate loads, therefore increasing hepatic glycogen stores. This process may
contribute to the enhanced endogenous glucose production seen in the aforementioned
study 51. Feah et al 51 suggested that the increased endogenous glucose production seen
in the high fructose diet can be explained by alterations in hepatic gene expression 51.
High carbohydrate diets stimulate carbohydrate response element-binding protein
(ChREBP), a hepatic transcription factor that up-regulates the expression of lipogenic and
glycolytic enzymes. ChREBP also regulates the expression of key enzymes of hepatic
fructose metabolism. Although ChREBP is primarily regulated by glucose through the
increase in intrahepatic glucose metabolites, Feah et al 51 specify that these enzymatic
reactions may also be stimulated by a high fructose diet.
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The most commonly proposed mechanism for the fructose-induced insulin
resistance in the previous studies appear to be the diminished ability of insulin to
suppress hepatic glucose output and decrease insulin receptor density apparent in skeletal
muscle and liver 73. Catena et al 73 found that insulin receptor number and mRNA levels
were significantly decreased in skeletal muscle and liver of fructose-fed rats (66%
fructose) after two-weeks compared to control rats. These findings suggested that a
down-regulation of insulin receptor gene expression is a possible molecular mechanism
for insulin resistance. Moreover, abnormalities in insulin action at a post-receptor level in
muscles and liver during fructose consumption may also occur such as decreased
phosphorylation of IRS-1 and decreased associated of IRS-1 with phosphatidlyinosotol 3kinase 74. This evidence shows that these early steps in insulin signaling are important for
insulin’s metabolic effect 75. Therefore, it is concluded that the mechanisms behind
fructose-induced insulin resistance is possibly due to the combination of various factors
such as a reduction in the number of insulin receptors in skeletal muscle and liver as well
as decreased phosphorylation, both caused by increased fat production.

e. Fructose-induced Hypertension:
The ingestion of fructose has also been associated with alterations in various
hemodynamic responses such as increases in heart rate and blood pressure 76. Numerous
reports of fructose-induced hypertension in rodents are apparent 31; however, the link
between fructose intake and high blood pressure in humans is mainly base on indirect
evidence 6. Animal studies have shown that fructose feeding for only two-weeks (66%
fructose) can cause systolic blood pressure to increase significantly above baseline values
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. Likewise, when rats are fed 60% of energy from fructose for eight weeks, systolic

blood pressure also increased significantly compared to the control rats 31. Similarly,
Nakagawa et al 13 reported that rats fed 60% fructose diet for ten weeks had elevated
systolic blood pressure compared to the controls study. Four weeks into the intervention,
half of the fructose-fed rats were treated with allopurinol, a xanthine oxidase inhibitor,
for the remainder of the 6 weeks. Xanthine oxidase is an enzyme that increases uric acid
levels leading to increased systolic blood pressure 13. The fructose-fed rats treated with
allopurinol had a significantly lower systolic blood pressure than their untreated fructosefed counterparts 13. Hence, a large dose of fructose increases blood pressure, possibly
from increased production of uric acid and when treated with a substance that inhibits the
activity of xanthine oxidase, the effects are reversed 13.
Hyperuricemia is considered a component of the metabolic syndrome 24.
Lowering uric acid levels has been found to ameliorate a number of features of metabolic
syndrome in fructose-fed rats such as hypertension, hypertriglyceridemia,
hyperinsulinemia, insulin resistance, renal vasoconstriction, glomerular hypertension and
renal microvascular disease 24. In the first step of fructose metabolism, the
phosphorylation to fructose 1-phosphate via fructokinase utilizes an ATP and the
accumulation of fructose 1-phosphate depletes hepatic ATP and generates adenosine
diphosphate (ADP). Metabolism of ADP stimulates adenosine monophosphate (AMP)
deaminase and increases the degradation of nucleotides to form uric acid 78. Thus ATP
depleting effects of fructose can cause a transient arrest of protein synthesis, production
of inflammatory proteins, endothelial dysfunction and oxidative stress 24.
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Similarly to the above-mentioned study, Sanchez-Lozeda et al 31also observed a
gradual increase in systemic blood pressure and plasma uric acids with increasing doses
of fructose consumption after rats were fed either 10% fructose solution, 60% fructose
solution or control solution for eight weeks. A direct relationship between increasing
fructose concentrations and increased blood pressure was observed 31. These
investigators also found a positive linear relationship between uric acid levels and
systolic blood pressure 31. Fructose ingestion, over a period of time, resulted in elevated
uric acid levels as well as increased systolic blood pressure. Thus, higher uric acid levels
induced by a 60% fructose diet may be partially responsible for these hemodynamic
alterations mentioned 31. Mazzali et al 79 also studied rats that were treated with a uric
acid supplement for three weeks. The treated rats developed hyperuricemia, resulting in
hypertension. These hyperuricemic levels were 7-to 8-fold higher than the control rats not
treated with the supplementation 79.
As early as 1967, serum uric acid levels have been shown to increase rapidly after
ingestion of fructose, resulting in increases as high as 2 mg/dl within one hour 80.
Although these increases seem transient, studies in which fructose-rich diets were fed
over several weeks exhibited elevated fasting uric acid levels 81. The Third National
Health and Nutrition Examination Survey (NHANES), which studied 14,791 participants
over the age of 20 years, found that hyperuricemia was associated with increased
consumption of sugar-sweetened beverages 82. The authors cited a study performed by
Fox et al 83 in 1974 which found that large amounts of fructose in the sugary drinks
increase ATP degradation to AMP which results in uric acid production. Fox at el 83 also
stated that with purine nucleotide depletion, rates of de novo purine synthesis is
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accelerated, thus potentiating uric acid production 83. In contrast, glucose and other
simple sugars do not have this effect. Based on the NHANES survey and previous
research, Choi et al 82 suggested that fructose has the ability to indirectly increase serum
uric acid levels, leading to an increased risk of gout as a result of increased circulating
insulin levels and eventually insulin resistance 82.
In a study with 4867 adolescents, dietary data gathered from a 24-hour recall led
researchers to observe the association between higher sugar-sweetened and elevated
serum uric acid levels and systolic blood pressure 84. In this cohort of subjects, serum
uric acid increased by 0.18 mg/dL and systolic blood pressure increased by 2 mmHg
from the lowest to the highest category of sugar-sweetened beverage consumption. In a
general normotensive adult population, a 2 mm Hg reduction of systolic blood pressure
would lower stroke mortality by 10% and ischemic heart disease by 7%. For every
1mg/dL increase in serum uric acid, there is a 7% increase in the development of kidney
disease or death after adjusting for multiple variables such as age, sex, race, systolic
blood pressure, alcohol, smoking, HDL-cholesterol, and baseline kidney function 82.
Another link between fructose, hyperuricemia and hypertension are defects in the
nitric oxide (NO) pathway leading to subsequent impairments in endothelial–dependent
relaxation 67. A diminished NO synthesis, release, or sensitivity of vascular smooth
muscle cells to NO may allow cells to become more susceptible to the effects of
vasoconstrictors, leading to enhanced vascular tone and elevated blood pressure 78. Uric
acid infusion in humans has led to impaired endothelial NO release which can be
reversed with allopurinol, an uric acid inhibitor 85. Likewise, when Nakagawa et al 13 fed
male Sprague-Dawley rats a diet containing 60% fructose for ten weeks, they observed
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that these rats had a significant increase in uric acid levels and inhibited NO
bioavailability compared to the rats fed a control diet. Furthermore, when those fructosefed rats were treated with allopurinol to lower uric acid levels, NO bioavailability was
enhanced and features of metabolic syndrome were lowered 13. Researchers have
speculated that the decreased bioavailability of NO is a result of decreased endothelial
nitric oxide synthase (eNOS) 86.
Although numerous animal studies indicate a relationship between fructose,
hyperuricemia and hypertension, there is limited direct human evidence of such effects.
One of the few human studies investigating the acute effect of fructose on hemodynamic
responses noted that consumption of a 500 ml drink containing 60 g of fructose by young,
healthy male and females, resulted in significant increase in blood pressure variability
and decreased cardiovagal baroreflex sensitivity up to two hours after the drink was
consumed. The increase in blood pressure was in response to the fructose load and was
also characterized by gradual increases in heart rate and cardiac output (although lower
than the glucose drink) with no compensatory reductions in total peripheral resistance 17.
In another study on healthy young men, an acute load of fructose/glucose (100 g)
or a glucose solution (100 g) resulted in no changes in blood pressure or uric acid levels
acutely 87. Other studies have also indicated that fructose doses as high as 30% of energy
intake in normal-weight 44 and overweight 49 individuals failed to significantly alter blood
pressure. Likewise, the Nurses’ Health Study reported that fructose was not associated
with the risk of developing hypertension 88. Hence, there is little human evidence as to a
cause and effect relationship between fructose and hypertension, but, high fructose intake
is linked to high caloric intake, weight gain and insulin resistance, all of which are
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independent risk factors for hypertension 6. These differences indicate a need for more
continued research as to how and if a high fructose diet induces hypertension in humans.
Research has indicated that uric acid dose-dependently blocks acetylcholinemediated arterial dilation, suggesting that uric acid can impair endothelial function and
reduce endothelial NO levels 13. This mechanism may be due to a blockade of insulin
action, as insulin stimulates glucose uptake in skeletal muscle by increasing blood flow to
tissues through the NO-dependent pathway 89. Insulin can then cause local vasodilation
mediated by endothelium-derived nitric oxide (EDNO) 90. The increased vasodilation
resulting from nitric oxide release enhances blood flow to the skeletal muscle, stimulating
glucose uptake into the cell 91. However, when uric acid levels are elevated from chronic
fructose ingestion, endothelial nitric oxide release is diminished, leading to decreased
blood flow. Decreased blood flow to the skeletal muscle will result in a decrease in
skeletal muscle glucose uptake, over-secretion of insulin and consequently
hyperinsulinemia 91. This provides supporting evidence that uric acid may have a
pathogenic role in risk factors associated with metabolic syndrome.
Although the aforementioned studies indicate that acute and chronic fructose
consumption induces hyperuricemia, a recent investigation by Bidwell et al 81
demonstrated that an acute load of high fructose corn syrup (100 g) does not induce
hyperuricemia in healthy, adult males. The researchers speculated that the dose used was
not high enough to elicit such changes in uric acid and that a healthy, adult male may be
protective against increases in uric acid 81. The results by Bidwell et al 81 were similar to
results by Wang et al 209 in which the authors researched 21 controlled feeding trials in
425 prediabetic/diabetic and nondiabetic participants and demonstrate that the uric acid
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response to fructose feeding differs between isocaloric and hypercaloric feeding
conditions. Studies which employed isocaloric fructose diets showed no changes in uric
acid levels yet when a hypercaloric fructose diet was employed, uric acid level did
increase. The contradiction between studies may be that a threshold for fructosemediated ATP depletion/AMP production, which is thought to lead to increased uric acid
concentrations, must occur. The mean fructose dose in the isocaloric trials (93.4 g/d) was
below the level of exposure associated with higher uric acid concentrations in the
observational studies, which may also have incompletely adjusted for energy
compensation. It was also well below the mean dose used in hypercaloric trials (215 g/d)
used to induce higher uric acid concentrations and the animal models (60% Energy as
fructose, which is equivalent to 300 g/d on a 2000-kcal diet) used to elucidate the
mechanism of fructose-induced uric acid production 209. A fructose dose threshold has
been observed in clinical trials, below which the effects on other metabolic biomarkers
are lost, e.g., ≤60 g/d in type 2 diabetes and <100 g/d across all subject types for TG 210.
Another possible explanation linking fructose to hypertension is the role of insulin
on cardiac contractibility. Although fructose does not increase insulin acutely, as
previously mentioned, chronic fructose ingestion leads to hyperinsulinemia which has
adverse effects on the sympathetic nervous system 2. Two potential explanations for this
link between hyperinsulinemia and hypertension are: 1) an increase in the sympathetic
neural outflow and plasma catecholamine concentrations associated with increased
plasma insulin concentrations; and 2) insulin action at the level of the proximal tubule
increasing fluid reabsorption 2. Currently research elucidating these mechanisms is very
limited 92. Considering hypertension is a well-known comorbidity associated with
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obesity, insulin resistance, hyperinsulinemia and hyperlipidemia 2, it is important to
determine the effects of fructose consumption on blood pressure in human subjects.

f. Conclusions:
The above review of literature summarizes the proposed mechanisms associated
with the fructose-induced metabolic alterations related to metabolic syndrome. These
risk factors, such as postprandial hyperlipidemia, insulin resistance, and hyperuricemia,
seem to be exacerbated with fructose ingestion in a dose-dependent manner; hence
continued research must be conducted to completely elucidate the importance of
decreasing fructose consumption.

II.

Inflammation
a. Hyperlipidemia and Endothelial Dysfunction:
Although triglyceride-rich lipoprotein (TRL) levels are typically high in a
dyslipidemic condition, they are also present in the normal, postprandial state and are
adequately cleared by the liver. In individuals with hyperlipidemia, the TRL remain
increased in circulation beyond the usual 4-8 hours 56 and this prolonged circulation
appears to be linked to accelerated atherogenesis. Triglyceride-rich lipoproteins are proinflammatory and can cause endothelial dysfunction, up-regulate expression of
endothelial adhesion molecules and promote macrophage chemotaxis. This process
occurs as a result of increased lipolysis of postprandial lipoproteins by lipoprotein lipase.
The adverse effect of this lipolytic action is the formation of small-dense LDL which
increase the permeability of the endothelial tissue, whereas lipolysis by fasting
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lipoproteins has no such effect 93. In the postprandial state, small-dense LDL are prone to
enter the arterial wall where they are ingested by macrophages and form foam cells. A
high prevalence of small-dense LDL are very common in patients with metabolic
syndrome, diabetes and insulin resistance 23.
The pro-inflammatory effects of elevated TRL are intricately linked to higher
concentration of small-dense LDL and lower concentrations of high-density lipoprotein
cholesterol (HDL-C). These small-dense LDL are unable to be cleared by the LDL
receptor, enhancing their potential for binding to proteoglycans, heavily glycosylated
proteins, in the vascular wall. Additionally, the small-dense LDL’s are more susceptible
to oxidation which will further increase their atherogenic potential 94. LDL oxidation is
mediated by the interaction with endothelial cells and other cells of the vascular wall.
Once inside the vascular wall, oxidized LDL’s further stimulate endothelial adhesion
activation and/or injury, stimulating adhesion molecule expression such as E-selectin, Pselectin, vascular adhesion molecules as well as monocyte chemoattractant protein1(MCP-1) which promotes activation and attachment of lymphocytes and monocytes 95.
Monocytes and leukocytes undergo diapedesis, the migration of blood cells
through the intact walls of blood vessels in the surrounding tissue, leading to
transmigration into the sub-endothelial space where they are differentiated into scavenger
cells 95. Oxidized LDL’s are ingested by scavenger cells leading to the formation of foam
cells. This process triggers the inflammatory process resulting in the immune system
releasing cytokines such as interleukin 1, 6, 8, TNF- α and NF-kappaB 96.

b) Hyperlipidemia, Inflammation and Insulin Resistance
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TNF-α, interleukin-6 (IL-6) and c-reactive protein (CRP), are important proinflammatory cytokines induced by elevated triglyceride concentrations which have been
linked to insulin resistance 97. Van Oostrom et al 98 have shown that increases in
postprandial TG and glucose stimulate the activation of neutrophils, leading to an
increase in pro-inflammatory cytokines such as IL-6 and TNF-α. IL-6 leads to increased
insulin resistance by blocking the IRS-mediated insulin signaling in hepatocytes and
muscle cells causing impaired insulin-stimulated glucose uptake into muscle cells 99.
Although the exact mechanism as to how IL-6 affects IRS receptors is not completely
understood, it could involve the activation of tyrosine phosphatase or an interaction
between suppressor of cytokine signaling (SOCS) proteins and the insulin receptor itself
100

. One of the primary effects of IL-6 is to induce the production of hepatic CRP which

is a known independent risk factor of cardiovascular disease 97. CRP is an acute phase
reactant inflammatory protein which reflects systemic low-grade inflammation 101. In
rodent models of glucose metabolism, infusion of IL-6 induced gluconeogenesis,
subsequent hyperglycemia, and compensatory hyperinsulinemia 101. Moreover, other
studies have demonstrated elevated levels of IL-6 and CRP levels among individuals with
features of the insulin resistance and type 2 diabetes 102. Given IL-6’s position in the
cytokine cascade as a key mediator of downstream inflammatory processes including
activation of coagulation, hepatic release of acute phase reactant proteins, IL-6 may have
a potential causal role in metabolic risk factors associated with type 2 diabetes and
cardiovascular disease.
TNF-α has been identified as the first molecular link between obesity, diabetes,
and inflammation and is over-expressed in adipose and skeletal muscle of obese mice and

40
humans 103. This phenomenon is apparent in experimental models in which
neutralization of TNF-α improved insulin sensitivity in obese rats. Moreover, TNF-α
deficient mice are protected from obesity-induced insulin resistance 103. Hotamisligil et
al 104 demonstrated that TNF-α disrupts insulin signaling by inducing serine
phosphorylation of IRS-1 which in turn causes serine phosphorylation of insulin
receptors. This process interferes with the normal tyrosine phosphorylation of the insulin
receptor, thereby interfering with normal insulin transduction 104.
The inhibition of insulin signaling by TNF-α in adipocytes and hepatocytes
involves the activation of a kinase utilizing IRS-1 as a substrate 105. Once serine is
phosphorylated, IRS-1 becomes a poor substrate for the insulin receptor and preventing
phosphorylation of serine restores IRS-1 mediated insulin receptor signaling 105. In the
liver, TNF-α infusion leads to decreased tyrosine phosphorylation of the insulin receptor
and insulin signaling molecules IRS-1 and Akt, indicating decreased insulin sensitivity
106

. Further, there is a strong positive correlation between TNF-α mRNA expression

levels in fat tissue and the levels of hyperinsulinemia 106. Likewise, TNF-α infusion
decreases tyrosine phosphorylation of insulin receptor IRS-1 and AKT in the intestine,
leading to increased production of apoproteinB-48 containing chylomicrons particles.
These changes accompany increased production of VLDL-type particles.
TNF-α stimulate I-kappa B (IκB) kinase-β (Iκκβ) to activate NF-κB which can
also alter insulin sensitivity 107. Once NF-κB translocates to the nucleus, the result is the
transcription of genes that promote the development of insulin resistance 107. The
induction of targeted genes by NF-κB leads to the increased expression of inflammatory
markers and mediators associated with insulin resistance. This process is associated with
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the production of other factors such as inflammatory mediators, chemokines and
transcription factors, all stimulating the recruitment of monocytes, eventually leading to
the differentiation of macrophages 107.
Previously, Hotamisligil et al 108 infused TNF-α or placebo into nine healthy
adults for four hours on two separate occasions. Using an euglycemic hyperinsulinemic
clamp, insulin resistance in skeletal muscle occurred when the TNF-α was infused;
however, endogenous glucose production was not altered. It appeared that TNF-α
directly impaired glucose uptake and metabolism by altering insulin signal transduction
108

. The authors reported that the insulin signaling pathway was associated with impaired

phosphorylation of Akt substrate 160 which is the most proximal step in the insulin
pathway and is responsible for the regulation of GLUT 4 translocation and glucose
uptake. Hence, it was concluded that excessive concentrations of TNF-α is linked to
negative insulin signaling and decreased whole-body glucose uptake in healthy adults 108.
Furthermore, Kanety et al 109 studied Fao hepatoma cells in vitro and established that
TNF-α caused a reduction in insulin-induced tyrosine phosphorylation of IRS-1 through
increased serine phosphorylation of the IRS-1 as a result of inhibition of serine
phosphates.
Previous studies have shown that increased consumption of fructose results in
hyperlipidemia accompanied by insulin resistance and elevated plasma triglycerides, all
leading to increased inflammation 51, 110, 111. Bergheim et al 111 found that rats fed a diet
with either 30% fructose, glucose, sucrose or water only for eight weeks, experienced
increased lipid peroxidation and elevated hepatic TNF-α in the fructose group compared
to all other conditions 111. The fructose diet increased TNF-α mRNA expression by 6.5
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fold. Lipid peroxidation led to induction of iNOS and TNF-α expression in the liver
when exposed to high levels of fructose. Moreover, the chronic intake of fructose, and to
a lesser extent sucrose, caused significant liver stenosis and increased neutrophil
production 111. Additionally, phosphorylation status of Akt in the liver was altered in
mice fed the fructose solution; however, a similar effect of fructose feeding was not
found in the TNF-α knockout mice. This implies that TNF-α may be critical in mediating
insulin resistance in mice chronically fed fructose 111. Additionally, it has been suggested
that an induction of TNF-α may suppress the activation of AMP-activated protein kinase
(AMPK) in the liver 112.
Kanuri et al 110 found similar results when wild-type mice or TNF-α knockout
mice were fed a 30% fructose solution or tap water for eight weeks. The authors were
examining whether TNF-α plays a critical role in the development of hepatic stenosis in
fructose-fed mice. Hepatic TG levels, markers of inflammation and ATP peroxidation
along with indices of insulin resistance were measured in the liver and plasma of the mice
110

. The fructose-fed, wild-type mice had significantly higher TG accumulation which

resulted in a 5-fold increase from baseline values. Moreover, the fructose-fed wild-type
mice had significantly higher neutrophil infiltration; whereas, in the fructose-fed TNF-α
knockout mice, the neutrophil infiltration was similar to the water-fed controls 110. In the
fructose-fed TNF-α knockout mice, hepatic stenosis and neutrophil infiltration was
attenuated which resulted in increased phosphorylation of AMPK and Akt, similar to the
water-fed controls. Since phosphorylation status of Akt in the liver was altered in the
fructose-fed mice wild-type mice and not the TNF-α knockout mice, it was concluded
that TNF-α and its receptor 1 may be critical in mediating insulin resistance in the mice
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chronically fed fructose 110. Spruss et al 113 found similar results when they tested mice
which were fed 30% fructose for five weeks.
In a longer duration study, Sanchez-Lozada et al 114 investigated whether a drink
containing 30% glucose with 30% fructose or 60% sucrose induced fatty liver when
compared to rats fed a standard show diet for 16 weeks 114. Liver inflammation was
induced as a result of elevated TNF-α with both the fructose + glucose diet as well as the
sucrose diet when compared to the control group (standard chow). The increases in
inflammatory markers significantly correlated with increases TG levels as well.
The aforementioned studies have indicated that increases in inflammatory
markers such as TNF-α can create changes in insulin signaling which can be exacerbated
with fructose ingestion 114. Although there is a lack of direct experimental evidence
linking fructose and inflammation, the process of lipid accumulation within the liver may
induce a sub-acute inflammatory response that is similar to that seen in obesity-related
inflammation within adipocytes 107. NF-κB is activated in the hepatocytes and cytokines
such as TNF-α, IL-6 and IL-1β are overproduced in fatty liver 107. These proinflammatory cytokines participate in the development of insulin resistance and activate
hepatic macrophages called Kupffer cells. Unlike adipose tissue in which macrophages
are relatively sparse in a basal state and increase with increased adiposity, the liver is
densely populated with Kupffer cells. Toll-like receptor 4 (TLR4) and CD14, receptors
on the Kupffer cell that internalize endotoxins activate the transcription of proinflammatory cytokines such as TNFα and interleukins. More research needs to be
conducted to fully elucidate the impact that fructose has on inflammation 107.
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III. Incretins, Fructose Ingestion and Metabolic Syndrome
Recent evidence has demonstrated that the incretin hormones may play a role in
the progression of T2D 115. The “incretin effect” implies that the ingestion of glucose
causes a release of substances from the intestines which act to enhance insulin secretion
beyond the release of absorbed glucose itself 116. A defective incretin response may
cause a severe postprandial hyperglycemic state 115. The hormones conveying this effect
are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide
(GIP); they are highly insulinotropic in a glucose dependent fashion 117. Both hormones
increase insulin secretion, however, only GLP-1 suppresses glucagon secretion 118. In
patients with type 2 diabetes, the secretion and/or action of incretin hormones is greatly
impaired, with GLP-1 defects being more pronounced than GIP 119.
Endogenous GLP-1is a gastrointestinal hormone secreted from the L-cells of the
distal aspect of the small intestine after the ingestion of nutrients, specifically glucose,
and is highly correlated with the release of insulin 118. GLP-1 is reduced in the fasted
state and increases rapidly after a meal. It has potent effects on the β-cell secretion of
insulin and is attenuated in T2D patients 118. Previous research has shown that the GLP-1
response to glucose in T2D is reduced by approximately 50% when compared to healthy,
glucose tolerant controls 119. Studies have shown that GLP-1 infusion in subjects with
T2D results in a near normal insulin response 115, 120. Glucose-dependent insulinotropic
polypeptide (GIP) is an incretin hormone secreted from the K cells of the duodenum in
response to an absorbed carbohydrate or lipid 115. GIP is reduced in the fasted state and
increases after food ingestion. The primary action of GIP is to stimulate glucosedependent insulin secretion 118.
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Significantly lower postprandial GLP-1 concentrations have been reported in
individuals with T2D. Toft-Nielsen et al 121 attempted to clarify the diminished incretin
effect when they studied 54 individuals with T2D and 33 glucose-tolerant following a
mixed meal four hours. They speculated that the decreased rate of gastric emptying seen
in the individuals with T2D may explain these occurrences. Delayed gastric emptying
rate may hypothetically increase the absorption of the proximal intestine resulting in less
food reaching the distal intestine where the L-cells are most abundant 121, thus, affecting
the amount and rate at which GLP-1 is released.
Knop et al 122 sought to determine whether the reduced incretin response observed
in individuals with T2D is a primary effect in the pathogenesis of the disease or rather a
consequence of the diabetic state. To do so they studied four different groups of subjects
with the following characteristics: 1) chronic pancreatitis and normal glucose intolerance,
2) chronic pancreatitis and secondary diabetes, 3) chronic diabetes, and 4) normal
controls 122. One two separate occasions, all groups underwent a four-hour study day
where they were administered either a 50g-oral glucose load or an isoglycemic
intravenous glucose infusion. The total GLP-1area under the curve was significantly
reduced in patients with chronic pancreatitis and secondary diabetes compared to those
with chronic pancreatitis with normal glucose tolerance and healthy controls 122.
Furthermore, the individuals with T2D group had a 36% lower incretin effect as
measured by: 100% x [β-cell secretory response of insulin and c-peptide to oral glucose
tolerance test-intravenous β-cell secretory response]/ β-cell secretory response to oral
glucose tolerance test, than in the chronic pancreatitis patients with normal glucose
tolerance and healthy controls. Additionally, the total GLP-1AUC was significantly
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greater during the oral glucose tolerance test than the intravenous infusion in all for
groups. Hence, the deficiency of GLP-1 and GIP seems to be more of a consequence of
the diabetic state rather than a primary pathogenic trait 122. Others 123 have also shown
that the GLP-1 response to a mixed meal is reduced in patients with T2D 124, 125, a
decreased insulinotropic potency of GLP-1126, and an almost complete loss of late phase
insulin secretion in response to GIP 127. Further exogenous GLP-1 administration
restores blood glucose regulation to near-normal levels in individuals with T2D as a
result of increased insulin secretion, reduced gastric emptying and decreased glucagon
production 128.
Verdich et al 129 compared GLP-1 and GIP concentrations in response to a meal in
obese and lean male subjects to determine whether weight loss affected the incretin
concentrations. Subjects were given a standardized meal test and plasma hormone levels
were measured every 30 min for 180 minutes. The obese subjects were retested after they
participated in a 6-month weight loss program in which the average weight loss was
18.8kg. After the 6-month intervention, the obese subjects were retested. Prior to the
weight loss intervention, GLP-1 area under the curve was significantly lower in the obese
subjects compared to the lean controls. At the end of the intervention, the obese subjects
had significantly higher GLP-1 concentrations than prior to the weight loss, however,
GLP-1 concentrations were still lower than the lean controls 129. These results implied
that GLP-1 concentrations begin to normalize gradually as weight is reduced. After the
intervention, both total and incremental area under the curve was lower in the weight loss
group compared to the lean controls. The impaired postprandial GIP response may reflect
a primary dysfunction in the obese state that contributes to hyperglycemia 129. From this
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study, it was not clear whether the reduction in postprandial GIP response after weight
reduction reflects a dysfunction in the GIP secretion in humans prone to obesity or rather
from the change in habitual diet 129.
Similar results were found in a study by Martins et al 130 in which weight loss
began to alter late postprandial increases in GLP-1 concentrations. Martins et al 130
induced weight loss with exercise training instead of dietary changes. Twenty-two
sedentary, overweight individuals exercised five times per week at 75% maximum heart
rate for a duration that elicited a 500 kcal/day deficit for 12 weeks 130. Although GLP-1
AUC levels were not significantly different prior to and after the 12-week exercise
intervention when a test meal was given, there was a tendency toward an increase in the
delayed release of GLP-1. During the last 90 minutes after the test meal, GLP-1
concentrations were higher than at the same time point during the pre-intervention 130.
Martins et al suggested that exercise-induced weight loss may improve satiety consistent
with the tendency towards an increase in the late postprandial release of GLP-1 130.
Although the effect of a glucose load on incretin hormones in obese with or
without T2D individuals is well elucidated, the response of such hormones to a load of
fructose is less studied. Kong et al 131 proposed that an oral load of fructose would cause
differing effects on GLP-1 concentrations than a similar load of glucose. On three
separate occasions, eight fasted, healthy controls ingested 75 g of fructose, 75 g of
glucose or 75 g of glucose + 75 g of fructose an hour later. Plasma GLP-1 concentrations
were measured for 180 minutes post drink consumption. Although all conditions elicited
an increase in postprandial GLP-1 concentrations, the largest increase in GLP-1was seen
with the glucose only group 131. Furthermore, ingesting a fructose load one hour after a
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glucose load did not alter the GLP-1 levels more so than when given separately.
Although fructose elicits postprandial increases in GLP-1 levels, they do not increase to
the same extent as a similar concentration of glucose 131. Research on fructose ingestion
and incretin hormones is lacking and further work is needed
IV. Physical Activity/Inactivity
a) Physical Inactivity
Physical inactivity and poor cardiovascular fitness has been consistently
associated with an increased risk of chronic diseases such as type 2 diabetes and
cardiovascular disease 30. Being physically inactive and/or unfit is associated with many
health consequences and is an important component of a comprehensive approach to
disease prevention and health promotion 132. Observational studies have demonstrated
that the most unfit individuals are at the greatest risk of chronic diseases and all-cause
mortality regardless of their gender, race, ethnic background or weight 5. Research
indicates that maintaining a high level of daily, low-intensity physical activity may be
important for preventing metabolic risk factors such as coronary artery disease, type 2
diabetes and hyperlipidemia 133. Recommendations are now emphasizing the importance
of incorporating moderate activity into a person’s daily routine in order to avoid the ill
effects of physical inactivity 134.
In 1953, Morris et al 135 determined that workers who were seated most of the day
such as bus drivers and telephonists were twice as likely to develop cardiovascular
disease than workers who stand or are ambulatory most of the work day such as mail
carriers. This study was reproduced more recently in 2005 136 in an epidemiologic study
of 73,743 postmenopausal women from the Woman’s Health Initiative Study in which
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those who were inactive had increased risk of cardiovascular disease and this was
reversed with increased activity 136.
The Australian Diabetes, Obesity and Lifestyle Study which included 8,299 adults
25 years and older with no known metabolic diseases reported that sitting time and selfreported television viewing was positively correlated with undiagnosed abnormal glucose
metabolism 137. These results persisted after adjustment for sustained and moderateintensity leisure-time physical activity. A subsequent study from the same Australian
cohort found that individuals (n=4064) who reported having participated in the required
dose of weekly physical activity (30min/day, 5x/week) still had detrimental waist
circumference, systolic blood pressure, and 2-hour plasma glucose after correcting for
such variables with television viewing time 138. In this same cohort, 1958 adults, over the
age of 60 years who reported high levels of sedentary behavior, had a greater prevalence
of developing metabolic syndrome 139. This data provides evidence that reducing
prolonged overall sitting time may reduce metabolic disturbances and that there is a need
for more specific sedentary behavior recommendations and health guidelines for adults in
addition to the current recommendations of physical activity 138.
Data from the Medical Expenditure Panel Survey indicated that both physical
inactivity and obesity are strongly and independently correlated with diabetes and
cardiovascular disease 140. According to the survey, the likelihood of having diabetes
increases with physical inactivity regardless of BMI, and at any given BMI classification,
it is better to be active than inactive. Hence, both physical inactivity and obesity seem to
be independently associated with diabetes and diabetes-related risk factors 140. Healy et
al 133 reiterated these findings when they observed that when 67 men and 106 women
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wore accelerometers for seven days, the subjects with the lowest activity patterns had the
highest 2-hr plasma glucose levels.
Not only does prolonged inactivity decrease the opportunity for cumulative
energy expenditure resulting from numerous muscle contractions 5, physical inactivity
also induces molecular changes. Within six to eight hours of physical inactivity, the
suppression of skeletal muscle LPL activity and reduced muscle glucose uptake occurs,
resulting in elevated plasma TG and reduced HDL levels 5. Lipoprotein lipase is an
important enzyme involved in the molecular alterations affecting physical inactivity 141.
It is synthesized by parenchymal cells such as muscle fibers and is secreted into the
extracellular fluid at which time it becomes functional on the intimal surface of the
vascular endothelium 142. LPL is the main enzyme responsible for the breakdown of
VLDL-TG and chylomicrons on the endothelial. LPL also enhances the removal of
VLDL by the VLDL receptor and indirectly plays a role in maintaining high levels of
plasma HDL-cholesterol. Hence, low LPL is associated with blunted plasma TG uptake
as well as reduced HDL levels 5. Local regulation of LPL provides a means of generating
a concentrated source of fatty acids as well as other lipoprotein-derived lipids 141.
Moreover, LPL is involved in the regulation of gene expression of inflammatory markers
which lead to cardiovascular disease 143.
Physical inactivity and/or muscle regulate LPL activity in the vasculature and
skeletal muscle. Reduced physical activity can decrease LPL activity in the
microvasculature 10-20 fold 134; but such decreases can be reversed within several hours
of ambulatory contractions implying that a reduction in contractile activity is a potent
physiological factor determining LPL activity 141.

51
The model of LPL response to physical inactivity and plasma lipid in the
microvasculature of skeletal muscle can best be described by first understanding the
mechanisms behind the LPL response during ambulation 144. During ambulation, the
vascular endothelial cells are at the interface with plasma TG and fatty acids bound to
albumin. During standing or ambulation, there is high LPL activity in the
microvasculature of the skeletal muscle. Physically active muscles have greater rates of
TG-derived fatty acid uptake, albumin-bound fatty acid transport, fatty acid oxidation,
and intracellular TG synthesis. Moreover, there are reduced concentrations of
intramuscular fatty acids and fatty acyl-CoA 144. In contrast, during inactivity when
normal metabolic processes has slowed down, there is a removal of the local energy
demands of physical activity, leading to an elevation in TG and fatty acids. Plasma fatty
acids and TG accumulate as a result of a lower rate of LPL-induced fatty acid oxidation.
This process can be reversed when pharmacological agents such as nicotinic acid lowers
the exposure of the muscle tissue to lipids, causing LPL activity to be maintained 141.
Bey et al 134 examined why regulation of LPL activity may be different during
states of inactivity versus activity. They studied rats who participated in low-intensity
training for 12 hours (active controls) versus rats that were inactive (hind-limb unloaded).
They hypothesized that the normally high activity of LPL in oxidative muscle would
significantly decrease with physical inactivity and that increased physical activity, after a
period of inactivity, would restore such effects. In this acute study, rats were unloaded
for 12 h followed by a loading period in which they performed walking and standing for
four hours. The 12 h of physical inactivity significantly decreased LPL activity and
within four hours of low-intensity activity, the LPL levels were increased back towards
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the active control rats levels 134. In conjunction with the changes seen with LPL, the
uptake of TG and HDL-C decreased. This study demonstrated that the steps involved in
muscle LPL regulation, which are sensitive to inactivity can be prevented and even
reversed with minimal, non-fatiguing contractions (ex: slow treadmill walking) 134.
Zderic and Hamilton 141 also examined whether decreased physical activity would
decrease LPL activity in rats. The hind-limb unloaded (HU) (inactive) rats experienced a
47% decrease in LPL activity after 8-h of inactivity and an additional 13% after 12 h of
inactivity. A secondary purpose of the study was to determine whether a high-fat meal
(~200 kcal/kg) would decrease LPL activity in the ambulatory controls. Plasma TG
concentrations were increased by 83% at the 12-h point which resulted in a 63% decrease
in LPL activity 141. They too concluded that decreased activity depresses LPL activity.
Furthermore, increased fat intake with ambulation also suppresses LPL activity, similar
to that of inactivity. These results parallel the previously stated concept that there is an
inverse relationship between TG concentrations and LPL activity and that decreased
activity amplifies the response.
In the Studies of Targeted Risk Reduction Intervention through Defined Exercise
(STRIDDE), the researchers investigated whether the training-induced benefits in serum
lipids and lipoproteins are sustained over five and/or fifteen days of exercise detraining.
Subjects were randomized into one of four groups; 1) high amount/vigorous intensity
(caloric equivalent to approximately 20 miles/week at 65%-80% peak oxygen
consumption, 2) low amount/vigorous intensity equivalent to approximately 12 miles per
week at 65% to 80% peak oxygen consumption and 3) low amount/moderate intensity
with a caloric equivalent of approximately 12 miles per week at 40%-55% peak oxygen
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consumption and 4) a control non-exercising group for six months. Plasma was collected
at baseline, 24 h, 5 days and 15 days after exercise cessation 145. This study demonstrated
that six months of exercise increased HDL-C levels which were sustained at 5 and 15
days after exercise cessation 145. Further, the modest-intensity training group reduced
total TG and VLDL-TG at 24 hours post- exercise training by twice the magnitude of the
two more vigorous exercise-training groups. In the two vigorous-intensity training
groups, total TG and VLDL-TG had returned to baseline after only 5 days, indicating that
there was no sustained TG-lowering effect in those two groups. While the mechanisms
for the aforementioned effects were unclear, the authors speculated that exercise of
different intensities may have tissue-specific effects on the LPL bound to the endothelial
cells, resulting in differential effects of exercise of varying intensities on TG, VLDL and
HDL metabolism 145.
Endurance athletes are also not protected from inactivity related alterations in
LPL changes. Herd et al 146 examined the influence of chronic aerobic training, followed
by a short period of detraining, on postprandial lipidemia. Fourteen recreationally active
males and females completed a 13-week running program in which the first 4 weeks
involved running for 20 minutes at a steady-state 3x/week, the next four weeks involved
interval training in conjunction with long, easy runs 5x/week and finished with a
maintenance phase for the remaining weeks 146. The following nine days the subjects
refrained from running. An oral fat tolerance test was conducted prior to the 13-week
protocol and again 15 h, 60 h and 9 days after the cessation of running. Sixty hours after
the last training session, the runners’ lipidemia response to the fat load was 37% higher
than baseline, and 46% higher after 9 days of detraining. These changes correlated with a
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reciprocal decrease in LPL activity 146. This data supported the previous hypothesis that
hydrolysis at the endothelial surface of capillaries by LPL is the rate-limiting step in TG
clearance, and changes in LPL activity with changes in exercise or training status are
most likely the cause of the above findings 146.
B) Physical Activity:
Physical activity has been shown to decrease body weight and visceral fat
accumulation 147, improve insulin sensitivity147, decrease plasma TG levels, increase
plasma HDL-C 148 and decrease blood pressure, all risk factors for metabolic syndrome
30

. Research has shown that walking is an effective way to increase the level of physical

activity and can be easily measured with the use of pedometers 149. Many public health
information sources recommend an average daily step count of 10,000 for adults and
12,000 for children that equal a caloric expenditure of approximately 300-400 kcal 149.
More specifically, the American College of Sports Medicine guidelines state that adults
should accumulate at least 30 minutes of moderate-intensity activity, preferably all days
of the week in order to protect against chronic diseases 132.
Physical exercise improves insulin sensitivity both acutely and chronically as a
result of changes in insulin signaling. This process is not mediated by the insulindependent rapid phosphorylation of the insulin receptor, IRS -1/2 on tyrosine residues
with a subsequent activation of PI3-K 150. In contrast, exercise stimulates an insulinindependent pathway. With a muscle contraction, glucose uptake is mediated by multiple
signaling pathways such as protein kinase-C, Ca+2/ calmodulin-dependent protein kinase
kinase (CaMKK) and AMPK 150. The translocation of GLUT 4 receptors to the cell
membrane occurs as a result of increased Akt activity and phosphorylation within the cell
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151

. This effect is short-lived, lasting 48-72 hours; therefore, to maximize the benefits of

physical exercise on insulin sensitivity exercise should be repeated within this timeframe.
The benefits of physical activity, such as lower serum TG levels, lower blood
pressure and increased insulin sensitivity, can be observed after a single bout of moderate
to vigorous intensity exercise 152. Increased physical activity activates LPL, which is
responsible for the partitioning of triglyceride-derived fatty acid uptake in various tissues
as well as increased cholesterol metabolism and downstream intracellular modifications
to lipid availability 134. A muscle contraction immediately stimulates an increase in
skeletal muscle LPL activity which increases TG clearance leading to an increase in
mitochondrial metabolic potential and an improvement in oxidation rates of long and
medium chain fatty acids, resulting in a reduction in intracellular ceramide productions.
Additionally exercise modulates hepatic lipase activity, hence decreasing TG-rich
remnant proteins and TG 25.
The use of pedometers is increasingly being targeted as a means to assess
increased physical activity and improve motivational levels for sedentary individuals. An
extensive literature review by Tudor-Locke and Bassett 153 determined that <5000
steps/day correlated with sedentary lifestyle, 5000-7499 steps/day was low-active, 75009999 steps/day was somewhat active, 10,000 and 12,499 steps/day was active and
≥12,500 steps/day was highly active. Achieving 10,000 steps/day has been widely
recognized by the media and general public as a target threshold for achieving health
benefits 153. Subsequently, achieving 10,000 steps/day may be a reasonable alternative
for compliance with public health recommendations to be moderately active thirty
minutes per day on most days of the week 153.
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In an attempt to determine whether pedometer usage could improve risk factors
associated with type 2 diabetes and cardiovascular disease, Freak-Ploi et al 154
investigated pedometer usage in 762 adults in the workplace 154. Participants were
required to walk a minimum of 10,000 steps per day for four months. The four months of
increased physical activity significantly decreased sitting time (as assessed via
questionnaires), improved blood pressure and decreased waist circumference (by 1.6 cm).
At the start of the intervention, 27% were not meeting the recommended physical activity
recommendations, 23% were above the recommended waist circumference guidelines,
54% had elevated blood pressure. At the conclusion of the 4-month intervention, all of
those participants were meeting the recommended guidelines in all categories, reducing
their risk for type 2 diabetes and metabolic syndrome 154. These results are similar to
previous workplace interventions in which significant decreases in waist circumference
occurs from increased physical activity 155-158.
Although there seems to be clear guidelines as to the amount of physical activity
needed in order to experience cardiovascular adaptations, there is still a debate as to the
amount of physical activity needed for weight loss. Results from the STRIDDE study
(previously described) have shown that eight months of exercise resulted in weight loss
in a dose-dependent manner with the high-dose group achieving the greatest weight loss
and no weight loss in the control group 159. The amount of weight loss is directly related
to the amount of exercise performed and calories expended.

c) Physical Activity and Inflammation
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Although exercise causes an acute inflammatory response 160, physical activity
and improved cardiovascular fitness decreases low-grade inflammation by decreasing
body fat, decreasing production of pro-inflammatory cytokines and increasing production
of anti-inflammatory cytokines. Moreover, exercise reduces expression of adhesion
molecules, up-regulates antioxidant and other cellular defenses and improves endothelial
function 161. Brandt et al 162 has suggested that cytokines and other peptides that are
produced, expressed and released by muscle fibers and exert paracrine or endocrine
effects should be classified as “myokines” such as IL-6, IL-8, and IL-15. Although lowgrade inflammation characteristic of elevated IL-6 levels has been associated with obesity
and insulin resistance, it is markedly produced and released after an acute bout of
exercise and may actually help to prevent or reduce risk factors associated with metabolic
syndrome and type 2 diabetes 162.
During exercise, the magnitude of the increase in IL-6 is relative to the duration,
intensity of exercise and amount of muscle mass involved. Muscle biopsies from humans
and rats have demonstrated increases in IL-6 after exercise up to 100 times that of resting
values 163. In response to muscle contraction, both type I and type II muscle fibers
express the myokine IL-6 which exerts its effects both locally within the muscle by
activating AMPK and peripherally in several organs of the body when released into
circulation. IL-6 may also work in an endocrine manner to increase hepatic glucose
production during exercise or during lipolysis in adipose tissue 164.
The anti-inflammatory effects of IL-6 have also been demonstrated by the ability
of IL-6 to stimulate the release of classical anti-inflammatory cytokines such as IL-1ra
and IL-10 164. Hence, IL-6 has both pro- and anti-inflammatory properties. When IL-6 is
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signaling monocytes or macrophages, the activation of NF-κB and TNF-α occurs, leading
to an inflammatory state but when IL-6 is released from muscle, it creates an antiinflammatory state 162. Therefore, the possibility exists that the long-term effect of
exercise may be a result of the anti-inflammatory process of an acute bout of exercise.
For that reason, acute exercise will protect against chronic systemic low-grade
inflammation and thereby offer protection against insulin resistance and atherosclerosis.
d) Fructose and Exercise:
For athletes, fructose provides a beneficial aid in training due to its ability to
stimulate rapid nutrient absorption in the small intestine and help increase exogenous
carbohydrate oxidation during exercise 6. When fructose is mixed with glucose in sports
drinks, carbohydrate oxidation is enhanced by 40%. This dramatic increase in oxidation
can be explained by the different transport systems used for intestinal absorption.
Moreover, fructose has been shown to reduce the perception of fatigue and stress during
exercise and improve exercise performance during cycling exercises 165.
To date, there is only one report of fructose and physical activity. Botezelli et al
26

studied 48 Wister Rats to determine whether aerobic exercise alters markers of fatty

liver disease when fed a diet high in fructose. Two groups of rats were studied for 90
days, control rats and fructose-fed rats (60% fructose). After 90 days, the fructose-fed
rats had decreased insulin sensitivity and increased total cholesterol and TG, whereas the
control rats showed no change 26. From days 90-120, the rats exercised one hour a day,
five days per week. At the end of the 120 days, the fructose-fed rats had altered metabolic
profiles which included elevated plasma TG as a result of the fructose diet, had improved
insulin sensitivity and decrease cholesterol levels, resulting from the exercise regimen.

59
The changes in TG levels were most likely due to the improved lipid oxidation and
availability of circulation TG as a result of exercise 26. These results indicate that
increased physical activity may improve features of metabolic syndrome. Studies on
humans still need to be conducted to determine the interaction between fructose
consumption and exercise.

IV.

Conclusions
Although it seems apparent that increased intake of fructose leads to various risk

factors associated with metabolic syndrome such as hypertension, hyperlipidemia, insulin
resistance, inflammation and hyperuricemia, there is still numerous contradictory
evidence which states that as long as fructose is consumed in moderate doses 210, fructose
may not augment these risk factors. The quantities of fructose administered in many of
the studies used concentrations that were well above the average fructose intake of 60-70
g/day, and with increased daily caloric intake, which may results in differing results.
Hence, there is a need for research investigating the effects of fructose when using
quantities that more closely match that of the average population to determine if fructose
is as harmful as research seems to state. Moreover, there is only one study indicating how
physical activity may alter such risks. Although fructose consumption cannot be
completely to blame for the increased rates of obesity and metabolic syndrome, fructose
is often associated with additional detrimental behaviors such as a hypercaloric diet, a
diet rich in saturated fats as well as low physical activity 6. These behaviors lead to risk
factors of metabolic syndrome and such could be prevented and/or reduced.
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Chapter III
ABSTRACT
High physical activity during fructose loading attenuates the postprandial lipidemic and
inflammatory responses to a fructose-rich meal.
Fructose consumption has increased substantially in the past few decades and has been
linked to hyperlipidemia. Whether increased physical activity (PA) may confer protection
against fructose-induced hyperlipidemia is yet to be determined. PURPOSE: The purpose of this
study was to determine the interaction between chronic high fructose consumption and PA levels
on postprandial lipidemia and inflammation in normal weight, recreationally active individuals.
METHODS: Twenty-two men and women (age: 21.2 ± 0.6 yrs; BMI = 22.5 ± 0.6 kg/m2)
consumed an additional 75 g of fructose for 14 days on 2 separate occasions: during the loading,
subjects maintained either low PA (~ 4,500 steps/day; FR+Inactive) or high PA (~ 12,500
steps/day; FR+Active). Prior to and immediately following the 14 days of fructose consumption,
subjects were given a fructose-rich meal (600 kcal mixed meal (45% carbohydrate [25%
fructose], 40% fat, and 15% protein). Blood was sampled at baseline and for 6 h after the meal.
Samples were analyzed for triglycerides (TG), very-low density lipoproteins (VLDL), total
cholesterol (TC), glucose, insulin, tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6) and creactive protein (CRP). Area under the curve (AUC) and absolute change to peak hormone
concentrations ((peak-baseline)(∆peak)) were calculated to quantify the postprandial responses.
RESULTS: Log transformed TG AUC significantly increased from pre (10.1 ± 0.1 mg/dL x min
for 6 h) to post (10.3 ± 0.08 mg/dL x min for 6 h; p = 0.04) with the FR+Inactive intervention;
whereas, TG AUC was unchanged after the FR+Active intervention. Additionally, the
FR+Inactive intervention resulted in an 88% increase in ∆peak[TG] (p=0.009) and an 84%
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increase in ∆peak[VLDL] (p=0.002) with no change in either variable after the FR+Active
intervention. IL-6 total AUC was not altered in either intervention, however, ∆peak[IL-6]
increased by 116% after FR+Inactive intervention but decreased 30% after the FR+Active
intervention (p=0.009). While there were no changes in glucose concentrations with either
intervention, insulin AUC significantly decreased after FR+Active intervention (p=0.04) with no
change in AUC after the FR+Inactive intervention. No changes were observed in TNF-α and
CRP concentrations (p>0.05). CONCLUSIONS: Low physical activity during a period of high
fructose intake augments fructose-induced postprandial lipidemia and inflammation in as little as
two weeks of consumption while high PA during fructose consumption appears to minimize
these metabolic disturbances. Hence, maintaining high PA may decrease the susceptibility to
cardiovascular risk factors associated with high fructose consumption.
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Introduction:
There is a growing body of evidence in animal and human models that a high dietary
intake of fructose is an important nutritional factor associated with development of insulin
resistance 12, fatty liver 13, hyperlipidemia15, 35 and hypertension 17; all risk these factors are
associated with metabolic syndrome. Fructose overfeeding has also been linked to reduced lipid
oxidation and increased triglyceride formation in healthy males 19 and obese adults 49. This is
evident in research conducted by Stanhope et al 49 who found that 25% of calories from fructose
induced hepatic insulin resistance, increased de novo lipogenesis and increased visceral adiposity
in obese adults within 10 weeks. Similiarly, Abdel-Sayed et al 19 found that a high fructose diet
(3.0 g/kg of body weight/day) for seven days suppressed lipolysis and lipid oxidation.
Researchers therefore, postulate that increased consumption of fructose might be one of the
environmental factors contributing to the development of obesity and abnormalites associated
with metabolic syndrome and cardiovascular disease 2, 19, 49. Although previous studies have
indicated adverse adaptations to a high fructose diet, these studies often use unrealistically high
levels of fructose 19 or study the subjects while they are sedentary 49, both of which could impact
metabolic outcomes related to fructose metabolism.
The metabolic problems associated with high fructose consumption are a result of the
unique metabolism of fructose. During fructose metabolism, fructose is rapidly phosphorylated
by fructokinase in the liver, but metabolism is not inhibited by the cellular energy state of the
cell, causing an influx of carbon atoms into the tricarboxylic acid cycle (TCA) leading to
increased acetyl CoA levels 166. Large concentrations of acetyl CoA can increase fatty acid
production, resulting in hepatic de novo lipogenesis. Simultaneously, fructose inhibits hepatic
lipid oxidation which favors fatty acid re-esterification and VLDL-triglyceride synthesis 76. The
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induction of fructose-induced lipogenesis results in an increase of TG to the adipose tissue and
ectopic tissues such as muscle and liver, increasing the size of these depots. This leads to
impaired insulin signaling, dyslipidemia, and low-grade inflammation 167.
The main limitations of previous research concerned with fructose consumption are that the
high fructose diet resulted in caloric excess 19 and/or there was no control in the level of physical
activity or sedentary behavior of the subjects. Sedentary behavior alone is known to decrease
LPL in as little as 8 h 134. LPL is a key regulatory enzyme responsible for the partitioning of
triglyceride-derived fatty acid uptake in various tissues as well as increased cholesterol
metabolism and downstream intracellular modifications to lipid availability associated with fat
breakdown 134. Low PA and fructose ingestion may interact synergistically to alter LPL activity
and/or lipid metabolism. Additionally, physical inactivity is inversely related to low-grade
inflammation as a result of increasing pro-inflammatory markers such as IL-6. Fructose
consumption may have an additive effect on inflammation as fructose increases low-grade
inflammatory markers such as monocyte chemo-attractant monocyte-1 168. Hence, the additive
effect of physical inactivity, combined with chronic fructose consumption may have a
confounding effect on metabolic abnormalities and may increase the risk for cardiovascular
disease.
While there is an abundance of research on the importance of increased physical activity to
prevent metabolic syndrome and heart disease, there is no evidence investigating the effects of
high fructose consumption under conditions of energy balance. Further, no previous research
has compared high physical activity and low physical activity on plasma lipid concentrations in a
fructose-fed state. Therefore, the purpose of this study was to examine the interaction between
high fructose consumption and physical inactivity on postprandial lipidemia and low-grade
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inflammation in a young, healthy population. It was hypothesized that a diet rich in fructose
would increase postprandial lipidemia more so when coupled with physical inactivity than when
accompanied by high physical activity. Moreover, we hypothesized that a high fructose diet over
a 2-wk period would increase pro-inflammatory markers associated with elevated lipid
production and these effects would be ameliorated with high physical activity.

Methods:
Subjects Characteristics:
Healthy male and females (n=22) between the ages of 18-25 years old were recruited from
the Syracuse University community. Subjects had to be recreationally active (3-4 days/week),
with a body mass index (BMI) < 27 kg/m2 (mean: 22.5 ± 1.6 kg/m2). All study participants
completed an informed consent form, approved by the Syracuse University Institutional Review
Board prior to participating in this study. Exclusion criteria included the use of lipid and/or
glucose-lowering medications or other medications that may affect glucose and lipid metabolism
(e.g. antidepressants, oral contraceptives, etc.), chronic NSAID usage (>2 x/week), daily
antioxidant supplementation, orthopedic limitations to walking, type 2 diabetes or glucose
intolerance, overt cardiovascular disease, hypertension, and/or an abnormal lipid profile.
Subjects were excluded if they were currently ingesting more than one high fructose drink/day
(>20 grams). Women started the intervention periods within the first 7 days of the menstrual
cycle to minimize the potential effects of estrogen on glucose/insulin levels 169.
Study Design:
Initially, subjects participated in a one–week control period before starting the intervention
to determine their normal physical activity and dietary habits. Through this control period, it
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was determined that the subjects mean steps/day were equal to 8,754 ± 173 steps. The first
intervention involved a two-week fructose loading period in which subjects ingested an
additional 75 g of fructose per day with an ad libitium diet while increasing physical activity to
>12,500 steps (FR+Active). This was followed by a two-week washout period. The second
intervention involved fructose loading while being physically inactive (<4500 steps)
(FR+Inactive). A study day with a fructose -rich meal was given at the beginning and after both
14-day interventions. This was a counter-balanced, cross-over design.
Pre-screening Visit: All subjects completed a medical history, physical activity and
sedentary behavior questionnaire prior to the start of the intervention. After a thorough review of
the subject’s activity level, the potential subjects were disqualified if their activity level included
regular exercise more than four times/week. Both the physical activity and sitting questionnaires
are in appendix C. Height and weight were measured, and body composition was assessed by airdisplacement plethysmography (BODPOD system, Life Measurement, Inc. Concorde, CA) 170.
After anthropometric measurements were completed, subjects performed a graded exercise test
on the treadmill using a protocol that has been previously published 171. Briefly, subjects began
exercising at 3.5 mph for two minutes at which time the speed increased by 1.0 mph up to 6.5
mph every two minutes. At that point the grade was increased by 2.5% every two minutes
thereafter. Subjects’ blood pressure, heart rate and rate of perceived exertion were monitored
throughout the test. The test ceased when the subject reached volitional fatigue 171.
At the conclusion of the initial visit, the subjects underwent a nutritional consultation with
a registered dietician to ensure proper compliance with the dietary intervention and to estimate
normal fructose intake. Subjects were instructed to refrain from ingesting any added sugar such
as sweetened beverages, fruit juices, pastries, and cookies aside from the study drinks, during the
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intervention period. Further, estimates of food intake during the control and intervention period
were collected by random 24-hour recall (via telephone) two times per week using the USDA 5step multiple-pass method 172. The same registered dietician administered the recall to all
subjects. Recalls were then analyzed using Diet Analysis Plus (version 7, Thomson Wadsworth,
Thomson Corporation, Independence, KY). Following the initial visit, the subjects began a oneweek control period at which time they continued with their normal activities of daily living and
typical diets. During this period, the subjects monitored their physical activity (steps) with the
use of an Accelerometer (Actigraph® GT3X Activity Monitor, Pensacola, FL) which was later
uploaded to the computer for further analysis. Subjects also were given pedometers (Accusplit®,
Livermore, Ca) to provide visual feedback regarding daily step count. Subjects were instructed to
not participate in any additional exercise during the study duration.
Visit 1: At the end of the 7-day control period, the subjects arrived at 0700 h, following a
12-h fast and no exercise 24 h prior to testing. Subjects had a catheter inserted into the
antecubital vein by a registered nurse. Subjects then rested in a supine position for 30 minutes
before obtaining two baseline blood samples (10 ml each). After baseline blood samples, a test
meal was prepared for subjects. The test meal included the following: 600 kcals, 45%
Carbohydrate (25% fructose, 20% Complex), 40% Fat, 15% Protein. After the test meal, blood
samples were obtained at the following time points: 5, 10, 15, 20, 30, 40, 50, 60, 75, 90, 120,
150, 180, 210, 240, 360 minutes. For the duration of the study day, subjects were instructed to
sit in a reclining chair and abstain from any strenuous activity.
Intervention: At the end of the study day, the subjects were randomly assigned to either the
high or low physical activity intervention. The high physical activity intervention required the
subjects to walk at least 12,500 steps per day, while the low physical activity intervention
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required minimal activity and ~4,500 steps per day. The subjects consumed a fructose-rich diet
containing 75 grams/day of fructose (two 20 oz Lemon Lime WPOP® drinks, Rochester, NY)
along with their ad libitum diet during both conditions. The use of an ad libitum diet was based
on the fact that sugar-sweetened beverages are usually consumed in conjunction with an ad
libitum diet 173. Previous research has indicated that within 7 days, metabolic abnormalities can
occur with a high fructose diet 19, therefore, a 2-week intervention was chosen to ensure changes
occur. The subjects obtained their beverage supply twice weekly at the Human Performance
Lab. They were required to return their empty drink bottles to the lab once per week to assess
drink compliance and to record step counts. During the FR+Inactive intervention, subjects were
instructed to reduce their caloric intake by ~400 kcal/day to offset the additional calories from
the drink. A dietician assisted in educating the subjects on how to alter their eating habits to
achieve caloric balance during the intervention period. Additionally, subjects had their weight
measured during these weekly visits to the lab to monitor any weight changes.
Visit 2: On day 15 following the 14-day intervention period, a post intervention meal test
was provided. This test followed the same procedures as visit one.
Two-week washout period. Subjects were instructed to maintain their normal activities of
daily living and dietary habits. Previous research has indicated that a two-week washout period is
adequate to normalize metabolic markers associated with hyperlipidemia 174.
Visit 3 and 4: These visits followed the same procedures as visit 1 and 2. For the second
intervention period, the subjects received the opposite intervention that was originally assigned
to them.
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Metabolic Assays:
Lipids:
A lipid profile (Cholestech LDX, Biosite International, San Diego, CA) was performed on
the samples taken at 0, 60, 120, 180, 240, and 360 min and measured triglycerides (TG), verylow density lipoproteins (VLDL), total cholesterol (TC), and glucose concentrations. The use of
this equipment has been recently validated 175.
Insulin, CRP, TNFα, IL-6:
Blood samples obtained at -5, 0, 5, 10, 15, 20, 30, 40, 50, 60, 75, 90, 120, 150, 180, 210,
240, 360 min were transferred to BD Vacutainer® Plus Plastic EDTA tubes (Franklin Lakes,
NJ), separated by centrifugation, divided into two sets of polypropylene tubes and stored at 80ᵒC for subsequent analysis. Insulin, tumor necrosis factor -α (TNF-α) and interleukin 6 (IL-6)
were analyzed using Luminex xMap Technology (Linco Research, St.Charles, MO) on a
Luminex 100/200 platform (Luminex Corporation, Austin, TX). All procedures followed the
manufacturer’s instructions (Millipore, Billerica, MA), with quality controls within expected
ranges for each assay (Insulin: Inter-assay coefficient of variation (CV): 5.0%; Intra-assay CV:
4.0%, TNF-α : Inter-assay CV, 9.9%; Intra-assay CV: 10.6%, IL-6: Inter-assay CV: 10.3; Intraassay CV 11.9%). CRP assays were performed using Quantikine assay kit (R&D Systems, Inc.,
Minneapolis, MN) [Inter-assay CV: 6.5%; Intra-assay CV: 4.2%]). Insulin sensitivity was
calculated by the homeostatic model assessment (HOMA) method as previously described by
Matthews et al 176 and the quantitative insulin sensitivity check index (QUICKI) 177.
Statistical Analysis:
All results were reported as mean ± SEM using SPSS 19.0 (Chicago, IL, USA).
Descriptive variables and dietary analysis were analyzed using a two-way repeated measures

69
analysis of variance to depict differences in pre and post intervention weight, BMI, % body fat
and macronutrient consumption. A between-subjects analysis was performed on all variables to
depict differences in genders. A log transformation (Log10) was used for data that was not
normally distributed based on visual appearance of skewed data. Transformations were applied
so that the data more closely met the assumptions of normality based on parametric analysis
statistical procedures 215. Lipid and inflammatory variables were analyzed using a three-way
ANOVA with repeated measures to assess the changes in lipid measures and inflammatory
markers over the 6-hour test day: 2 (high vs. low physical activity) x 2 (pre vs. post intervention)
x 18 (time points). If a significant interaction was found, differences between timepoints were
analyzed using a paired t-test with Bonferroni correction factor. Postprandial responses for all
blood variables were determined by calculating area under the curve (AUC) (Excel, Microsoft
Corporation, Redmond, WA) and absolute change from peak to baseline concentrations (Δpeak)
for all variables. Statistical significance for AUC and Δpeak concentrations was computed using
a two-way repeated measures ANOVA (intervention x pre-post). Pearson’s correlation
coefficient was computed to determine any correlations between fasting TG and inflammatory
variables. A priori significance was set at 0.05.
Results:
Subject Characteristics: Table 1 represents the subject characteristics of the study
participants. Males were significantly heavier, taller and had a lower body fat percentage than
the females (p< 0.05). There were no significant differences in weight (Pre: 67.4 ± 9.1 kg, Post:
66.9 ± 10.2 kg), BMI or % body fat after either intervention (data not shown). There were no
gender differences in any of the lipid or inflammatory markers; therefore, all subjects were
combined for further analysis. Changes in fasting metabolic, inflammatory and glucose
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homeostasis markers for pre- and post- intervention are noted in Table 2. No significant
differences were evident in fasting measurements for all variables due to either intervention.
Moreover, there were no significant correlations between lipid and inflammatory markers (p >
0.05).
Table 1: Descriptive Statistics
Males (n=11)

Females (n=11)

Age (yr)

20.8 ± 0.7

21.5 ± 0.9

Weight (kg)

76.5 ± 4.1*

58.4 ± 1.9

Height (cm)

178.6 ± 2.3

167.3 ± 2.3

2

BMI (kg/m )

23.9 ± 0.9*

21.1 ± 0.5

Body fat (%)

13.8 ± 2.5*

23.6 ± 0.6

VO2 (ml/kg/min)

46.7 ± 1.2

42.0 ± 1.2
†

Active Intervention (steps/day)
13,959 ± 719
12,584 ± 413
Inactive Intervention (steps/day)
4291 ± 160
4155 ± 245
Values are mean ± standard deviations. BMI: Body Mass Index; VO2max: Maximum aerobic
capacity. *p<0.05 for differences between genders. †p<0.05 differences between intervention
steps.
Table 2: Fasting Metabolic Characteristics per and post intervention
Pre-Active Post-Active Pre-Inactive Post-Inactive
Lipid Markers
Triglycerides (mg/dL)
82.5 ± 9.5
88.1 ± 11.1
81.0 ± 11.1
80.1 ± 7.3
VLDL (mg/dL)
16.3 ± 1.9
17.4 ± 2.2
19.6 ± 4.2
16.0 ± 1.5
Total Cholesterol (mg/dL)
145.2 ± 6.7
150.4 ± 6.3
142.1 ± 5.7
148.4 ± 6.5
Inflammatory Markers
TNF-α (pg/ml)
4.8 ± 0.4
4.8 ± 0.3
4.6 ± 0.5
4.7 ± 0.4
IL-6 (pg/ml)
6.4 ± 1.3
5.7 ± 1.3
8.0 ± 2.4
7.2 ± 2.1
C-Reactive Protein (ng/ml)

1001.5 ± 307

831.0 ± 234

1228.7 ± 306

972.8 ± 258

Glucose Homeostasis Markers
Glucose (mg/dL)
79.9 ± 1.5
80.3 ± 2.3
78.5 ± 1.4
78.5 ± 1.4
Insulin (pmol/L)
104.8 ± 9.2
108.5 ± 9.1
124.3 ± 20.0
98.0 ± 5.5
HOMA-IR
2.9 ± 0.5
3.0 ± 0.5
3.5 ± 1.1
2.6 ± 0.3
QUICKI Index
0.56 ± 0.03
0.71 ± .05
0.82 ± .05
0.52 ± 0.04
Mean ± standard error of the mean (SEM). *p<0.05. HOMA-IR: homeostasis model assessment
of insulin resistance; VLDL: very low density lipoproteins. TNF-α: Tumor Necrosis Factor-α;
IL-6: Interleukin-6. (n=22)
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Dietary Analysis: The caloric intake was not different between the intervention periods and
we observed no change in subject body weight. This suggests that the subjects were in energy
balance during each intervention. Likewise there was no difference in the macronutrient
composition between the interventions (Table 3). The subjects consumed an additional 75 g of
fructose per day from the drink provided (500 kcal, 0 g of fat, 135 g of carbohydrates, 74.9 g of
fructose). As with most dietary analysis software, the fructose included in most foods was not
available in the dietary analysis.
Table 3: Average daily energy and macronutrient intake between the two interventions.
FR+Active
Intervention
Calories (kcal)

2,654 ± 205

Fat (g)

65.2 ± 5.2

%-Cals
22%

FR+Inactive
Intervention
Calories (kcal)

%Cals
2404 ± 197

Fat (g)

57.8 ± 4.1

Saturated

18.9 ± 0.9

Saturated

14.2 ± 1.5

Monounsaturated

23.5 ± 0.4

Monounsaturated

11.0 ± 0.9

Polyunsaturated

30.0 ± 0.6

Polyunsaturated

12.6 ± 2.1

Cholesterol (mg)

595.0 ± 19.9

Cholesterol (mg)

503.0 ± 23.0

21%

Protein (g)

116.8 ± 10.8

17%

Protein (g)

115.2 ± 14.6

19%

Carbohydrates (g)

339.9 ± 25.1

61%

Carbohydrates (g)

360.6 ± 19.0

60%

Fiber (g)

22.1 ± 0.7

Fiber (g)

19.0 ± 1.7

Sugar (g)

185.0 ± 5.3

Sugar (g)

199.0 ± 10.3

Mean ± SEM
Glucose and Insulin: The test meal induced a significant postprandial response in both
glucose and insulin levels (p< 0.05) (Fig. 4 A-B). Glucose total AUC and postprandial changes
in peak concentrations were not different after either intervention but a significant intervention x
time interaction occurred in insulin concentrations (p=0.04). Insulin total AUC for FR+Active
intervention decreased from pre to post intervention, whereas, there was no change in insulin
AUC after the inactive intervention (Fig. 4B). These differences in AUC can be accounted for
by a 19% lower peak insulin response after the FR+Active intervention while FR+Inactive
condition was 21% higher post-intervention (p= 0.009) (Fig. 4C).
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Figure 4: (A) Postprandial response to the test meal on glucose concentrations. (B) Postprandial
response to the test meal on insulin concentrations and Insulin total AUC. (C) Δpeak insulin
concentrations. Data are expressed as mean ± SEM. *p<0.05 significant intervention x time
interaction. † p<.05 for main effect of meal.
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Triglycerides: Triglyceride concentrations significantly increased in response to the test
meal under both interventions (p= 0.000) (Fig. 5A). Total AUC for TG concentrations showed a
significant intervention x time interaction such that the tAUC increased from pre- to postFR+Inactive intervention; whereas, there was no change from pre-to-post FR+Active
intervention (p= 0.04) (Fig. 5B). Similarly, ∆peak[TG] increased by 88% as a result of the
FR+Inactive intervention but decreased by 5% (p= 0.002) with the FR+Active intervention (Fig.
5C).
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Figure 5: (A) Postprandial effects of the test meal on triglyceride concentrations. (B)
Triglyceride total AUC during the 6-hour test visits. (C) Change in triglyceride concentrations
from baseline to peak levels. Data are expressed as mean ± SEM. *p< 0.05 intervention x time
interaction. †p< 0.05 for main effect of meal.
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Very-Low Density Lipoproteins (VLDL): Figure 6a represents the 6 h postprandial
response of VLDL concentrations after a test meal. Both pre- and post- FR+Active and
FR+Inactive interventions demonstrated a significant main effect across time for VLDL
concentrations at which point concentrations peaked at 3 h (p= 0.029). Change in [VLDL]
induced a significant intervention x time interaction such that the change from pre to post
FR+Inactive intervention was significantly larger than the change from pre to post FR+Active
intervention. The inactivity induced an 84% increase in ∆[VLDL] whereas only a 33% increase
following the FR+Active intervention (p= 0.009) (Fig. 6B).
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Figure 6: (A) Postprandial effects of the test meal on VLDL concentrations. (B) Change in
VLDL concentrations from baseline to peak levels. Data are expressed as mean ± SEM. *p<0.05
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intervention x time interaction. †p< 0.05 main effect of meal.
Cholesterol: Although subtle, there was a significant main effect across time following the
meal for total cholesterol (p=0.03) (Fig 7), but total AUC and ∆[Cholesterol] was not
significantly different between interventions (figure not shown).
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Figure 7: Postprandial response of the test meal on total cholesterol concentrations. Data are
expressed as mean ± SE. †p<0.05 main effect of meal.
TNF-α: In response to the fructose test meal, a significant meal effect (p=0.02) was
observed for TNF-α concentrations, such that the test meal resulted in an increase in TNF-α
concentrations over the course of the 6 h (Fig. 8), however, no changes occurred in CRP
concentrations over time (figure not shown). The FR+Active and FR+Inactive interventions did
not result in any differences in TNF-α or CRP AUC or change from peak-baseline concentrations
(p>0.05).
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Figure 8: Postprandial response of the test meal on TNF-α concentrations. Data are expressed
as mean ± SEM. †p<0.05 for main effect of meal

In response to the test meal, IL-6 levels showed a significant main effect of time (p=0.02)
(Fig. 9A). Change in IL-6 concentrations demonstrated a significant intervention x time
interaction such that IL-6 levels decreased by 30% following the FR + Active intervention while
they increased by 116% following the FR+ Inactive intervention from pre to post intervention
(p=.048) (Fig. 9B).
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Figure 9: (A) Postprandial effects of the test meal on IL-6 concentrations. (B) Change in IL-6
concentrations from baseline to peak levels. Data are expressed as mean ± SEM. *p<0.05
intervention x time interaction. †p< 0.05 meal main effect
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Discussion:
The purpose of the current study was to determine whether a moderate dose of excess
fructose (~75 g/day), ingested for two weeks with an ad libitum diet, would alter the
susceptibility for metabolic risk factors associated with metabolic syndrome while
simultaneously manipulating physical activity. This study has shown for the first time, that
physical inactivity augments the TG and VLDL response to a high fructose meal, as well as
enhances the inflammatory response (IL-6 concentrations). These changes were not observed
when fructose was consumed while an active lifestyle was maintained, suggesting that the high
physical activity offsets the metabolic stress that leads to these hyperlipidemic changes.
Previous research has already suggested that a chronic fructose diet induces hepatic DNL,
causing an increase in plasma TG and VLDL concentrations 19, 49, 178. For instance, Stanhope et al
49

found increases in DNL after 10 weeks of fructose loading (25% energy intake) in overweight

individuals. Shorter fructose intervention studies (< 3weeks) have discovered similar findings in
that increased fructose intake of up to 2 g/kg of body weight/day induced hepatic DNL, leading
to increased release of VLDL-TG particles into the systemic circulation 19, 179. In agreement with
these studies, postprandial TG and VLDL concentrations were elevated in the current study (88%
and 84% from baseline, respectively), indicating possible increased hepatic DNL.
During physical inactivity, there is an increased concentration of VLDL-TG’s which
accumulate most likely as a result of a lower rate of lipoprotein lipase (LPL)-induced fatty acid
oxidation 141. LPL is responsible for hydrolyzing TG’s associated with VLDL and chylomicrons
and has a central role in several aspects of lipid metabolism such as the partitioning of
triglyceride-derived fatty acid uptake between different tissues, plasma cholesterol metabolism
and the subsequent downstream intracellular effects related to lipid availability 142. Levels of
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LPL are reduced by10-20 fold within 12 hours of physical inactivity and may be the contributing
factor to increased lipid formation present in the FR + Inactive intervention 142. During
ambulation in which the larger muscles of the body are contracting, there is high LPL activity in
the microvasculature of the skeletal muscles. Physically active muscles have greater rates of TGderived FA uptake, transport and oxidation, which result in reduced FA re-esterification 141.
Consequently, during times of inactivity, when energy demands are low, there is an
accumulation of TG and fatty acids within the skeletal muscle. In the current study, the elevated
postprandial systemic TG and VLDL concentrations during the FR+Inactive intervention could
indicate that there was a blunted response of LPL-derived uptake of these fats.
Research by Mamo et al 180 found that fructose-fed rats had decreased concentrations of
LPL activity compared to glucose-fed rats after 10 weeks and this coincided with decreased
clearance of VLDL-TG in liver of the fructose-fed rats. Similarly, Roberts et al 181 indicated that
TG clearance at the level of the forearm is decreased after a high fructose diet, as a result of
decreased LPL activity hydrolysis of VLDL-TG. Although LPL activity was not specifically
measured in the current study, the increased VLDL and TG concentrations in the plasma may
have been due to suppressed LPL activity resulting from low physical activity. Taken together,
the inability of our subjects to hydrolyze VLDL-TG, as a result of decreased LPL activity, as
well as increased fructose-induced hepatic DNL, may explain the fructose-induced increases in
plasma TG concentrations following FR+Inactive intervention. Therefore, fructose, combined
with decreased physical activity may be contributing factors related to the elevated plasma lipids
present after periods of physical inactivity.
Although glucose was unaffected by the fructose consumption, insulin levels were 19%
lower with increased physical activity. This is consistent with previous research showing
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decreased plasma insulin concentrations with physical activity 150. Regular physical activity has
beneficial effects on insulin resistance by enhancing insulin signaling, glucose transport and
substrate metabolism in muscles 150. Consequently, the increased plasma TG and VLDL
concentrations from the FR+Inactive intervention may have caused by an increase in ectopic fats
which interfered with second-messengers within the muscle cell responsible for insulin signaling
and glucose disposal 49. Therefore, despite the fact that a high fructose diet increases plasma
lipids, which may alter the insulin signaling cascade, increased physical activity seems to offset
these deleterious consequences, mostly likely by increasing substrate utilization for energy.
Thus this highlights the importance of maintaining high physical activity when the dietary intake
is poor.
While it seems apparent that increased physical activity causes a decrease in insulin
secretion and plasma insulin concentrations, as is evident in the current study, research has
indicated that increased levels of plasma lipids may also interfere with insulin sensitivity by
simultaneously stimulating a rise in tissue inflammation 26, 183. Our data from the low physical
activity arm of the study support this concept as the high fructose diet elicited a 116% increase in
peak postprandial IL-6 concentrations, while simultaneously responding to the fructose intake
with increased peak postprandial TG and VLDL concentrations. These results are similar to
those by Hojbjerre et al 184 who showed that low levels of physical activity were associated with
increased levels of CRP, IL-6 and TNF-α. Other studies 183 also show evidence of increased
postprandial lipemia being associated with increased pro-inflammatory cytokines. Though the
current study did not find changes in CRP and TNF-α values, the increases in plasma lipids and
IL-6 concentrations contribute to the hypothesis that hyperlipidemia and inflammation are
linked. Consequently, increased lipid accumulation that occurs with a high fructose diet may be
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exacerbating the lipid-induced inflammation that occurs when a low physical activity lifestyle is
maintained for an extended period of time. Furthermore, fructose-induced lipid accumulation
may play a larger role on inflammation in an obese population, in which low-grade inflammation
is often already present 185.
The postprandial lipoproteins that are produced with chronic, high fructose, low physically
active lifestyle can activate leucocytes in the blood and up-regulate the expression of leucocyte
adhesion molecules on the endothelium, facilitating adhesion and migration of inflammatory
cells into the sub-endothelial space. One of the known effects of IL-6 is to induce the production
of hepatic CRP concentrations which is an independent risk factor of cardiovascular disease 97.
Earlier studies have found increased fasting CRP concentrations in healthy subjects ingesting
chronic levels of fructose for at least three weeks 185, 186. We did not find any changes in CRP
levels after either intervention, but our lack of response in CRP levels may be due to the length
of the interventions. Our study was only two weeks in duration while the other studies were at
least three weeks long 185,187. Moreover, our study was performed on healthy, young individuals,
whereas previous studies indicating changes in inflammatory markers with fructose ingestion
have been performed on an obese population 48, 168. Obesity itself can increase the release of
various adipokines, leading to systemic low-grade inflammation, therefore making it difficult to
determine the extent of fructose-induced inflammation 188. In addition, previous studies 187 have
shown increases in body weight by as much as 7% of baseline, while we kept energy intake
balanced between interventions and the subjects did not experience a weight gain. Thus, the
increases in CRP levels in the previous studies may have been linked to the weight gain
particularly if it was in the visceral region 189.
Exercise is a known protector against increases in inflammatory markers 190 and this may
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have accounted for the 30% decrease in IL-6 levels observed with physical activity. The
increases in IL-6 levels that occur with exercise are known to stimulate the release of many antiinflammatory cytokines which may cause a long-term effect of lowering low-grade inflammation
and chronic IL-6 release 191. On the contrary, physical inactivity has been shown to result in
significantly elevated inflammatory markers in as little as 10 days of bed rest. Therefore, not
only does physical activity increase the release of anti-inflammatory cytokines, physical
inactivity also stimulates the release of pro-inflammatory markers. Although pro-inflammatory
markers are often up-regulated with physical inactivity, the addition of physical activity did not
cause any change in TNF-α activity. These results were not unexpected as research has suggested
that TNF-α is not affected by exercise 189. TNF-α and IL-6 are both known to reduce the
expression of insulin substrate receptor-1 and GLUT 4 receptors in adipocytes as well as
decrease insulin-stimulated glucose transport. Therefore, low-grade inflammation may be an
important risk factor predisposing an individual to insulin resistance and type 2 diabetes 184.
In conclusion, a diet consisting of an additional 75 grams of fructose for two weeks
increased postprandial lipidemia and systemic inflammation when combined with physical
inactivity. This is the first study to our knowledge to provide evidence that high physical activity
can minimize the deleterious effects of high fructose consumption in healthy, recreationally
active individuals and thus minimizing their susceptibility to both metabolic and cardiovascular
risk factors.
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Chapter IV
Abstract:
Increased physical activity alters the fructose-induced glycemic response in healthy
individuals
Chronic fructose consumption has been positively associated with insulin resistance and
decreased insulin sensitivity while exercise is known to positively impact glycemic control by
increasing glucose uptake and decreasing insulin secretion. Whether increased physical activity
(PA) attenuates the deleterious effects of chronic fructose consumption on glycemic control
(FR+Active) has yet to be studied. Purpose: The purpose of this investigation was to determine
the effect of high fructose consumption on glucose tolerance and the insulin response when
combined with either high or low levels of physical activity. Methods: Twenty-two normal
weight men and women (age: 21.2 ± 0.6 years; BMI: 22.6 ± .6 kg/m2) participated in a
randomized, cross-over design study in which they ingested an additional 75 g of fructose for 14
days while either maintaining low PA (FR+Inactive) (<4,500 steps/day) or high PA (FR+Active)
(>12,000 steps/day). Prior to and following the 2 wk loading period, a fructose-rich meal
challenge was administered (45% carbohydrate [25% fructose], 40% fat, and 15% protein).
Blood was sampled at baseline and for 6 h after the meal and analyzed for glucagon-like peptide
1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), c-peptide, glucose and insulin
concentrations. Area under the curve (AUC) and absolute change from peak to baseline
concentrations (∆peak) were calculated to quantify the postprandial responses. Results: Plasma
insulin, glucose, c-peptide, GIP and GLP-1 concentrations significantly increased in response to
the test meal on all test visits (p<0.05). Insulin total AUC decreased with the FR+Active
intervention from pre- (58,470.2 ± 6261.0 pmol/L) to post- (49,444.3 ± 3883.0 pmol/L)
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intervention; whereas, there was no change after the FR+Inactive intervention (pre: 53,005.4 ±
5426 pmol/L; post: 53,939.6 ±5429 pmol/L), resulting in a significant intervention x time
interaction (p< 0.05). The alterations in AUC coincided with decreased ∆peak[Insulin] from
peak values which also decreased after the FR+Active intervention while FR+Inactive
intervention increased in response to the intervention (P= 0.009). A significant intervention x
time interaction occurred for c-peptide incremental AUC, such that the FR+Active intervention
decreased by10,208 ±120 pmol/L x min for 6 h from pre to post intervention and increased by
16,230 ± 221 pmol/L (p= 0.02) after the FR+Inactive intervention. GLP-1 total AUC (n=16)
decreased by 18% after FR+Active intervention and by 6% in the Fr+Inactive intervention (PNS). Males had a lower total GLP-1 AUC than females after the interventions (p=0.049).
Following the FR+Active intervention GIP total AUC significantly decreased as a result of the
intervention with no changes occurring after the FR+Inactive intervention (p= 0.005). There
were no sex differences in GIP levels. Conclusions: Increased physical activity attenuates the
deleterious effects on glycemic control caused by a two-week period of high fructose
consumption when compared to low physical activity. These changes in glycemic control with
physical activity are associated with decreases in insulin and GIP concentrations.

86
Introduction:
There is strong epidemiological evidence suggesting a causal role between fructose
consumption and metabolic disorders 179. Chronic fructose consumption has been linked to
hyperlipidemia, visceral adiposity, hyperglycemia and decreased insulin sensitivity, leading to an
increased risk for developing metabolic syndrome and type 2 diabetes 19, 48, 49, 178. More
specifically, the long-term consumption of fructose in healthy, overweight subjects has resulted
in increased levels of glucose, insulin, triglycerides, glucagon-like peptide-1 (GLP-1) and
glucose-dependent insulinotropic polypeptide (GIP) 7, 178. Overweight individuals who
consumed 28% of energy from sucrose (50% fructose, 50% glucose) for 10 weeks experienced
increased energy intake, body weight, fat mass, blood pressure and reduced insulin sensitivity
compared to non-nutritive sweetener controls 192. Similarly, Stanhope et al 49 found that when
overweight males and females were fed an ad libitum diet rich in fructose (25% energy intake)
compared to glucose (25% energy intake) for 10 weeks experienced reduced insulin sensitivity.
Although both of these studies concluded that a chronic high fructose diet contributed to
increased hepatic lipid accumulation, increased adiposity and decreased insulin sensitivity 49, 192,
the subjects did not maintain energy balance throughout the intervention. Thus, it is difficult to
determine whether these results occurred as a result of caloric imbalance or the fructose itself.
Further, an overabundance of fatty acids, glucose and/or amino acids can also negatively impact
insulin sensitivity as well 193. In order to fully elucidate the metabolic ramifications of a high
fructose diet, maintaining energy balance and in turn body weight is necessary.
In addition, most of these previous studies 10, 16-18, 48, 49 did not measure physical activity
during the intervention period, and low physical activity can alter glycemic control. Postprandial
glucose levels and insulin sensitivity are improved with increased levels of physical activity 194.
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Specifically, when middle-aged women participated in light to moderate physical activity for 2
minutes every 20 minutes for five hours, their glucose response to a glucose bolus prior to the
first exercise session was significantly reduced at two hours as compared to a condition of no
activity 195. For aerobic exercise training, such as running and swimming, skeletal muscle
myofibers take on a slow- twitch phenotype, with an increase in the levels of oxidative enzymes,
glycogen, and glucose transporter 4 (GLUT4), allowing for enhanced glucose uptake into the cell
151

.
Although regular physical activity has undisputed health benefits, such as glucose

control, the majority of Americans do not meet the minimum physical activity guidelines 211, and
there are recognized deleterious effects of low physical inactivity 141. Low levels of physical
activity decreases energy expenditure and lowers plasma concentrations of lipoprotein lipase
(LPL), a key enzyme responsible for the uptake of chylomicron-rich triglycerides from the blood
141

. The loss of LPL activity during periods of prolonged physical inactivity can lead to

decreased uptake of plasma TG and decreased TG hydrolysis. Consequently, the increased TG
that remain in the plasma can increase adipose tissue and skeletal muscle ectopic fats, blunting
the sensitivity of insulin and decreasing glucose uptake to the cell 65. Unpublished research in our
lab has shown that increased fructose consumption increased plasma TG concentrations. Hence,
physical inactivity combined with a fructose-rich diet may increase the potential for insulin
resistance and hyperglycemia, exacerbating a state of positive energy balance by suppressing
LPL activity 65.
To date, there is minimal research investigating the role of chronic fructose consumption
and decreased physical activity on glycemic homeostasis. Therefore, the purpose of the current
study was to determine whether a high fructose diet combined with differing levels of physical
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activity altered glycemic control. It was hypothesized that a diet rich in fructose (75 g/day) for
two weeks in conjunction with decreased physical activity would negatively alter glycemic
control, while a fructose-rich diet and high physical activity (PA) would maintain glucose
control.

Methods:
Subject Characteristics:
Twenty-two male and female subjects between the ages of 18-25 years old were recruited
to participate in the study. Inclusion criteria were: being recreationally active (3-4 structured
workouts per week), a body mass index (BMI) of < 27 kg/m2, and a percent body fat of less than
23% for males and 30% for females. Exclusion criteria included suffering from overt
cardiovascular disease, hypertension and/or an abnormal lipid profile; taking lipid and/or
glucose-lowering medications, anti-depressants, chronic use of NSAID’s (>2x/week), daily antioxidants usage and suffering from any orthopedic limitations which may inhibit increased
physical activity. Subjects were also excluded if they were currently ingesting more than one
high fructose corn syrup drink (>20 g) per day. The women were studied during the first 10 days
of their menstrual cycle. All subjects completed an informed consent approved by the Syracuse
University Institutional Review Board.

Study Design:
This study employed a cross-over design where all subjects consumed a high fructose diet
(75 g/day) while either increasing physical activity to >12,000 steps/day (FR+Active) or
decreasing physical activity to less than 4,500 steps/day (FR+Inactive). A two-week washout
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period occurred between the two interventions. Both interventions were preceded by and
concluded with a six-hour study day in which subjects were given a high fructose meal test prior
to six hours of metabolic testing.
Pre-Screening visit: After completing a medical history questionnaire, informed
consent, and physical activity questionnaire, subjects had their height, weight and body fat
(BODPOD System, Life Measurements, Inc., Concorde, CA) measured. A graded exercise
treadmill test was employed using a protocol previously described 171. Following this visit,
subjects were instructed to participate in a one-week control period in which they were required
to wear a pedometer (Accusplit Eagle, Livermore, Ca) and an Accelerometer (ActiGraph, GT3X
Activity Monitor, Pensacola, FL) in order to collect baseline physical activity data.
Testing Days: Subjects came to the lab at 0700 h following a 12 h fast and no exercise for
the previous 24 h. A catheter was placed in their antecubital vein by a registered nurse and then
subjects rested for 30 minutes in a supine position before obtaining two baseline blood samples
(10 ml each). After baseline blood samples, a high fructose test meal (600 kcals ) was prepared
for subjects with a macronutrient composition of 45% Carbohydrate (25% HFCS, 20%
Complex), 40% Fat, 15% Protein. Blood samples were obtained at time points -5, 0, 5, 10, 15,
20, 30, 40, 50, 60, 75, 90, 120, 150, 180, 210, 240, 360 minutes. For the duration of the test
visit, subjects were instructed to sit quietly. At the end of visit one, subjects underwent a
nutritional consultation with a registered dietician to ensure proper compliance with the dietary
intervention and to estimate normal fructose intake. At that time, subjects were instructed to
refrain from ingesting any added sugar, particularly from sweetened beverages, aside from the
drinks for the intervention. Estimates of food intake during the control period and intervention
period were collected periodically via food recall (USDA 5-step multi-pass method) 172 and were
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analyzed using Diet Analysis Plus (Thomson Corporation) by a registered dietician.
Physical Activity: At the end of visit one, subjects were randomized into either a
physically active condition (FR+Active) which required them to walk at least 12,500 steps/day
for two weeks or the physically inactive condition (FR+Inactive) which required subjects to walk
<4,500 steps/day. All subjects completed both conditions. To assure compliance to the physical
activity intervention protocol, subjects were given an accelerometer to wear throughout the 2week intervention. Data from the accelerometer was downloaded to the computer using ActiLife
5.0 software (ActiGraph, Pensacola, FL). To allow for visual feedback, subjects were also given
a pedometer (Accusplit Eagle, Livermore, CA) to wear during the intervention.
Dietary Intervention: During the intervention period, subjects were required to ingest
two 20 oz Lemon Lime (WPOP®, Wegmans Corporation, Rochester, NY) drinks which was
equivalent to an additional 75 g of fructose, along with their ad libitum diet. To ensure subjects
did not increase body weight with the addition of the intervention drinks, a registered dietician
counseled all subjects in making dietary adjustments in order to maintain energy balance
throughout the intervention period. Twice weekly, subjects obtained their drink supply from the
Human Performance Lab and also returned their empty bottles as a measure of drink compliance.
At that time, subjects were weighed to ensure weight maintenance.
Washout Period: At the end of the first intervention period, subjects underwent a second
testing visit following the same testing procedures as visit one measuring metabolic and
hormonal changes induced by the intervention. Upon completion of this intervention, a twoweek wash-out period was required in which subjects were instructed to maintain their normal
activities of daily living and dietary habits. Previous research has indicated that a two-week
washout period is an adequate duration to normalize any metabolic disturbances that may have

91
been induced by the intervention period 174. Visit three took place immediately following the
washout period and followed the procedures of visit one. After visit three, subjects participated
in the two-week intervention (FR+Active or FR+Inactive) that was not initially performed during
the first intervention (counter-balanced, cross-over design). At the conclusion of the second
intervention, subjects underwent the last testing.

Metabolic Assays:
Glucose: Plasma glucose levels were measured using the YSI 2300 STAT Plus™ Glucose
& Lactate Analyzer (YSI Incoporated and Xylem, Inc.).
Hormone Assays: Blood samples were obtained and transferred to BD Vacutainer® Plus
Plastic EDTA tubes (Franklin Lakes, NJ), separated by centrifuging for 18 minutes, aliquotted
into two sets of polypropylene tubes and stored at -80ᵒ C for subsequent analysis. The following
metabolites were analyzed: GIP (Inter-assay coefficient of variation (CV): 3.9%; Intra-assay CV:
5.9%), GLP-1(Inter-assay CV: 5%; Intra-assay CV: 12%), insulin (Inter-assay CV: 6.1%; Intraassay CV: 4%), and c-peptide (Inter-assay CV: 6.5%; Intra-assay CV: 3.2%) using a Luminex
xMap Technology (Linco Research, St.Charles, MO) on a Luminex 100/200 platform (Luminex
Corporation, Austin, TX). All procedures followed manufacturer’s instructions (Millipore,
Billerica, MA) with quality controls within expected ranges for each assay.

Statistical Analysis:
Data was analyzed using SPSS 19.0 (IBM® SPSS® Statistics, Chicago, IL, USA) and all
results are reported as mean ± SEM. Descriptive statistics were analyzed using a 2 (pre vs. post)
x 2 (high vs. low activity) repeated measures analysis of variance (ANOVA) to depict
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differences. A paired t-test was performed to measure differences in steps between interventions
to ensure adequate alterations in physical activity load between interventions. Hormone
concentrations were analyzed using ANOVA with repeated measures to assess the changes in
postprandial response: 2 (high vs. low physical activity) x 2 (pre vs. post intervention) x 18 (time
points) with a between subjects gender variable. Changes in total and/or incremental area under
the curve (AUC) (trapezoidal method) and absolute changes in peak concentrations (peakbaseline) (Δ peak [hormone]) for all variables was determined using a 2 (low PA/high PA) x 2
(pre/post) repeated measures ANOVA). A priori significance was set at 0.05.

Results:
Subject Characteristics: Subject characteristics (weight, height, age, BMI, body fat,
aerobic capacity, step count) are presented in Table 4. There were no differences in weight (kg),
BMI (kg/m2), body fat (%) and VO2max (ml/kg/min) after either intervention (p>0.05). Males had
a significantly lower BMI and % body fat (p<0.05). As planned, the steps per day for the
FR+Active intervention (range: 11,567-18,845 steps) were significantly higher than the
FR+Inactive intervention (range: 2,774- 5,629 steps) for both males and females (p= 0.00).
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Table 4: Subject Characteristics.
Pre-Active
Post-Active Pre-Inactive Post-Inactive
Age (yr)
21.15 ± 2.8
n/a
n/a
n/a
Weight (kg)-MALES *
74.6 ± 1.9
74.1 ± 1.8
75.2 ± 1.2
75.5 ± 2.0
Weight (kg)- FEMALES *
59.9 ± 4.1
60.1 ± 4.0
60.4 ± 4.1
59.6 ± 4.1
Height (cm)
172.5 ± 2.0
172.5 ± 2.0
172.5 ± 2.0
172.5 ± 2.0
Body Fat (%)
18.7 ± 1.6
18.6 ± 1.6
18.7 ± 1.9
18.9 ± 1.7
2
BMI (kg/m )
22.5 ± 0.6
22.1 ± 0.7
22.9 ± 0.9
22.9 ± 0.8
VO2 (ml/kg/min)
44.7 ± 4.1
n/a
n/a
n/a
HOMA-IR
2.9 ± 0.5
3.0 ± 0.5
3.5 ± 1.1
2.6 ± 0.3
QUICKI Index
0.56 ± 0.03
0.71 ± .05
0.82 ± .05
0.52 ± 0.04
†
Physical Activity (steps/day)
n/a
12,586 ± 438
n/a
4223 ± 143†
Values are mean ± standard error of the mean (SEM). *p<0.05 difference between sex. †p=0.00
difference between interventions.
Dietary Analysis: Table 5 depicts the macronutrient composition determined from the dietary
logs during both interventions. There were no significant differences between the total calories
consumed and the percent of total calories from carbohydrates, proteins and fats between the
interventions (p>0.05). The intervention drink consisted of an additional 75 g of fructose per day
(500 kcal, 0 g of fat, 135 g of carbohydrates, 74.9 g of fructose).

Table 5: Dietary Analysis (n=20)
FR+Active
Amount
Intervention
Calories (kcal)
2,654 ± 205
Fat
22%
Protein
17%
Carbohydrates
61%
Values are mean ± SEM *p<0.05

FR+Inactive
Intervention
Calories (kcal)
Fat
Protein
Carbohydrates

Amount
2,404 ± 197
21%
19%
60%

Insulin and Glucose: The fructose-rich test meal stimulated an increase in glucose and
insulin concentrations postprandially on all test days (Fig 10A & 10B, respectively) (p<0.05).
Glucose concentrations peaked at 40 min post-ingestion, returning to fasting values by 120 min

94
and then rising slightly again between 120-240 min (Fig. 10A), whereas, insulin concentrations
peaked at 15 min post-ingestion and returned to fasting levels at 240 min (Fig. 10B). No
changes were apparent in glucose AUC or Δpeak[Glucose] (Figures not shown). A significant
intervention x time interaction for insulin total AUC occurred such that the FR+Active
intervention decreased from pre- (58,470 ± 6267 pmol/L x min for 6 h) to post- (49,444 ± 3883
pmol/L x min for 6 h) intervention; whereas, there was no change after the FR+Inactive
intervention (pre: 53,005 ± 5426 pmol/L x min for 6 h; post: 53,292 ± 5479 pmol/L x min for 6
h) (p=0.04) (Fig.10C). Additionally, the ∆peak[Insulin] decreased after the FR+Active
intervention but increased after FR+Inactive intervention (p<0.05) (Fig. 10D).
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Figure 10: Postprandial response to the test meal on (A) glucose concentrations, (B) insulin
concentrations, (C) insulin total AUC, and (D) ∆peak Insulin concentrations. Mean ± SEM.
*p<0.05 significant intervention x time interaction. ‡ p< 0.05 significant main effect for
intervention, †p< 0.05 significant main effect of meal. (n=22)
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C-peptide: Similar to glucose and insulin, c-peptide levels increased significantly in response to
the test meal (p=0.00) (Fig. 11A). Moreover, the c-peptide incremental AUC for the FR+Active
intervention decreased by10,208 ± 3300 pmol/L x min for 6 h from pre to post intervention while
c-peptide levels increased by 16,230 ± 4501 pmol/L x min for 6 h with the Fr+Inactive
intervention (p=0.04) (Fig 11B). As a measure of β-cell function, the ratio of ∆c-peptide (30
min-0 min)/∆Glucose (30 min-0 min) was calculated. There were no changes in β-cell function
with the interventions (data not shown)
A
Test Meal
FR+Active pre
FR+Active post
FR+Inactive pre
FR+Inactive post

C-peptide (pmol/L)

900
750
600
450
300

†
*

150
0

0

60

120

180

240

300

Time (min)

C-Peptide iAUC (pmol/
L x min for 6h)

B

*

360

Pre
Post

60,000
50,000
40,000
30,000
20,000
10,000
0

FR+Active
FR+Inactive
Figure 11 (A): Postprandial c-peptide response to a test meal. (B) incremental AUC c-peptide
(pmol/L x min for 6 h). †p=.000 main effect of test meal. * p=0.048 significant intervention x
pre/post interaction. Data are expressed as mean ± SEM. (n=22)
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GLP-1: There were 2 subjects eliminated from the 22 subjects due to undetectable ranges,
therefore GLP-1 and GIP values are based on an N=20. GLP-1 concentrations demonstrated a
significant main effect of time in response to the test meal (p<0.05) which was reflected by a
decrease during the last three hours (Fig. 12A). There was a significant gender x time (pre/post)
interaction such that GLP- 1 total AUC in females increased from 13,509 ± 2488 pg/ml x min for
6 h to 14,829 ± 2357 pg/ml x min for 6 h post intervention yet males decreased from 13,328 ±
1967 pg/ml x min for 6 h to 10,877 ± 1863 pg/ml x min for 6 h, regardless of the intervention
(p=0.049) (Fig. 12B). No changes were evident in peak GLP-1 concentrations.
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Figure 12 (A): Postprandial GLP-1 (pg/ml) response to a test meal. †p=0.000 main effect of test
meal from 180 min to 360 min. (B) total AUC GLP-1(pg/ml x min for 6 h). *p=0.049 gender x
pre/post interaction. Data are expressed as mean ± SEM. (n=20)
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GIP: GIP concentrations demonstrated a significant time effect over the course of the meal
(p=0.00). GIP increased for the first 75 min postprandially, followed by a decrease over the next
4.5 h in all meal tests (Fig.3A). Following the FR+Active intervention, there was a significant
interaction between the intervention and the test meals (p=0.047). Incremental GIP AUC
decreased by 5,603 ± 921x min for 6 h pg/ml from pre to post FR+Active while GIP AUC
increased by 3,231 ± 657 x min for 6 h pg/ml following the FR+Inactive intervention (Fig. 3B,
p= 0.047).
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Figure 13 (A): Postprandial GIP response to a test meal. †p= 0.00 main effect of test meal. (B)
Incremental AUC GIP (pg/ml x min for 6 h). *p=0.047 intervention x pre/post interaction. Data
are expressed as mean ± SEM. (n=20)
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Discussion:
The purpose of the current study was to determine whether decreased physical activity,
combined with chronic fructose consumption, altered glycemic control while energy balance was
maintained. Although previous studies have already elucidated that chronic fructose
consumption negatively alters glycemic control 49, 64, this was the first study, to our knowledge,
to demonstrate that increased physical activity attenuates the deleterious hormonal changes
associated with a fructose-rich diet. Despite no changes in glucose levels, chronic fructose
consumption, combined with increased physical activity, elicited decreased insulin secretion (cpeptide levels) and plasma insulin concentrations. Paralleling the changes in insulin secretion
was a decrease in GIP levels with increased physical activity, yet no change in GLP-1
concentrations were evident. This study demonstrated that high physical activity conferred
protection from poor dietary habits by minimizing the susceptibility to metabolic disturbances.
Modifying physical activity level in the present study did not alter the glucose excursions
to the meal test. In contrast however, increased physical activity decreased insulin secretion (cpeptide concentrations) by 27%, leading to a 15% decrease in plasma insulin concentrations after
the FR+Active intervention. Although c-peptide and insulin are released from the pancreas in a
1:1 ratio, 50% of insulin secreted is removed on first pass by the liver before reaching circulation
216

therefore, the lower plasma insulin concentrations, compared to c-peptide levels, were

expected. Stephens et al 193 demonstrated a 19% increase in plasma insulin concentrations with
no changes in plasma glucose concentrations after subjects remained sedentary during a 24-hour
period. These researchers speculated that changes in insulin action without a corresponding
change in glucose concentrations may have been caused by changes in β-cell function. In the
current study, we observed no changes in β-cell function but did find increases in peak
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postprandial c-peptide concentrations (43%) after the FR+Inactive intervention. It is possible
that with a longer period of inactivity, in conjunction with a high fructose diet, elevations in
glucose levels may occur via mechanism that were not measured in this study. Consequently, in
the face of a high fructose diet and physical inactivity for two weeks, the hormones monitoring
glucose control are being modified.
Moreover, peak insulin concentrations occurred sooner than the peak glucose levels. In a
healthy, adult population, insulin levels are expected to peak approximately fifteen minutes after
peak glucose concentrations, however, in the current study, insulin levels peaked prior to glucose
15

. The healthy, active population that was studied may explain this phenomenon as research has

demonstrated that active individuals have an increased incretin-stimulated insulin response 198.
Therefore, we speculate that the increased peak insulin concentrations, prior to the peak glucose
concentrations occurred as a result of insulin being potentiated by the incretin hormones.
Periods of inactivity are known to decrease LPL activity 194, and this suppressed LPL may
possibly contribute to changes in insulin concentrations during the FR+Inactive intervention 194.
Although LPL activity was not specifically studied in the current investigation, insulin action can
be decreased by as much as 18% after one-day of physical inactivity due to decreased LPL
activity 193. The decreased appearance of LPL during periods of inactivity suppresses the uptake
and utilization of plasma TG, resulting in increased ectopic fats 130. In other data from this same
project, increased peak postprandial TG concentrations (84%) and very low-density lipoproteins
(88%) were observed within two weeks (data not shown). Similarly, Stanhope et al 49 found that
chronic fructose consumption at 25% energy intake increased the average 23-hour postprandial
TG concentrations by 38.1 mg/dl after 10 weeks of a high-fructose diet. Increased TG formation
is a result of increased fructose-induced hepatic de novo lipogenesis 49, which synthesizes fatty
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acids into TG. Thus, the combination of a fructose-rich diet, which increases plasma lipids 49,
and low physical activity, which decreases LPL activity 201, insulin sensitivity may be modified.
Over an extended period of time, ingesting a diet high in fructose while maintaining a sedentary
lifestyle, may lead to insulin resistance.
In many of the prior fructose loading studies, caloric intake is not carefully monitored 43, 47
resulting in the subjects being out of energy balance. A strength of the current study was that
energy balance was maintained throughout the intervention period, hence we can attribute the
changes observed in insulin action to the decreased physical activity, and not an energy deficit.
Although energy balance was maintained, increased plasma TG concentrations from the high
fructose diet (data not shown) may have contributed to the elevated insulin concentrations by
negatively affecting cell-signaling associated with insulin receptors 139. The changes observed in
insulin secretion (c-peptide levels) may have been to counteract these changes. In the long term,
the disruption in insulin cell signaling resulting from elevated TG’s may cause decreased glucose
uptake into the cell, possibly inducing a hyperinsulinemic state if not balanced with increased
physical activity.
One novel finding of the current study was the GIP response to increased physical activity.
The decrease in GIP levels mirrors the changes in c-peptide levels such that both hormones
decreased with physical activity and increased with physical inactivity. This data suggests that
the changes in the insulin response to the meal test after increased physical activity may not only
be due to changes in insulin sensitivity 150 but may be mediated by alterations in GIP secretion.
Likewise, previous research by Kelly et al 198 and Solomon et al196 noted that increased long-term
physical activity, in conjunction with a hypo-caloric diet, suppressed the GIP-induced insulin
secretion from pancreatic cells, suggesting that increased physical activity relieves β-cell stress
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by inducing changes in β-cell and k-cells, helping to restore normal incretin function 198.
Although Kelly et al 198 suggested that it was the energy deficit induced by the hypo-caloric diet
in combination with the exercise that decreased the GIP levels 196, 198, in the present study, there
were no differences in energy intake or energy expenditure between the two interventions,
therefore other mechanisms must be mediating the decreased GIP response in the physically
active intervention. Further, other studies 212, 213 have shown an attenuation of GIP levels after a
glucose load in exercise-trained individuals, and reported that this was a result of cellular
changes within the β-cells of the pancreas and the K cells of the intestine 198. Interestingly,
however, is that fructose seems to augment the GIP release from k-cells. Mazzaferri et al 204 has
revealed that high levels of sucrose, which is made up of 50% fructose, over-activates the k-cells
of the intestine, subsequently leading to increased GIP-induced insulin secretion from the
pancreas. Hence, even though a high-fructose diet increases GIP response to a test meal, 204
during periods of high physical activity, the increased insulin sensitivity resulting from the
exercise decreased the need for GIP-induced insulin secretion, yet the identification of the
specific mechanism could not be accomplished in the current study.
Unlike GIP levels, GLP-1 concentrations did not respond to the physical activity loading or
unloading. The lack of significance may have occurred due to the smaller sample size used for
the GLP-1 analysis or that GLP-1 may not be as sensitive to changes in physical activity as GIP.
Furthermore, the gender differences that were detected with GLP-1 concentrations may have
altered the findings. Prior research has noted higher GLP-1 AUC in females than males, possibly
because of the higher percent body fat in women 207. We observed gender differences following
the meal test with the males showing an 18% decrease in GLP-1 AUC following the both
interventions while females demonstrated an increased GLP-1 AUC (9%) post-interventions.
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Gender differences have also been reported in other peptides such as resistin, adiponectin, and
leptin and may be related to increased percent body fat but also may be related to differences in
sex steroids 214.
As with all human research, there were strengths and limitations to this study. A major
strength of the current study was that the fructose load consumed by the subjects was more
closely aligned with the average fructose intake of the US population 10. Many of the earlier
studies 19, 49 used doses that were extremely high, thus these findings have less external validity.
Furthermore, although the subjects participated in an ad libitum diet, there were no weight
changes indicating subjects were in energy balance. This is in contrast to a previous study 49 in
which weight gain occurred while on a high fructose, ad libitum diet, confounding the
interpretation of their findings. The weight maintenance observed in the present study, allows us
to conclude with confidence that the changes observed in glycemic control and insulin section
were due to the changes in physical activity level and not weight changes. Lastly, the inclusion
of both males and females in our study demonstrated that gender appears to play a role in the
GLP-1 response to physical activity and fructose consumption, but not with the other metabolic
hormones.
In conclusion, our findings demonstrated that increased physical activity conferred
protection from the fructose loading. Increased physical activity attenuated fructose-induced
GIP release and may be subtly impacting β-cell function with the resultant effect of a decreased
insulin secretion, in the face of no change in glucose level. Consequently, chronic long-term use
of fructose combined with physical inactivity could cause an increase in deleterious risk factors
associated with insulin resistance. Moreover, GLP-1 responses to fructose loading and physical
activity seem to be gender dependent and further research is need in this area.

104

CHAPTER V:
Conclusions, Strengths/Limitations, and Future Perspectives
I. Conclusions:
Chronic consumption of fructose-sweetened beverages has been associated with
hyperlipidemia, hyperinsulinemia, and obesity 42. Due to the contradictory research 43,47, 51
available today, the aim of the current investigation was to better elucidate whether a high
fructose diet, in which concentrations were more similar to that of the average U.S. daily intake,
can result in postprandial lipidemia, low-grade inflammation and altered glucose homeostasis in
as little as two weeks. A sedentary lifestyle often accompanies a diet rich in sugar, therefore, we
examined whether increased physical activity with a high-fructose diet (75 g) for two weeks
would alter postprandial plasma concentrations of TG, VLDL, cholesterol, TNF-α, IL-6, glucose,
insulin and GIP and GLP-1 hormones.
This study has determined that a moderate, relevant dose of fructose, in conjunction with
physical inactivity, increased postprandial lipidemia and low-grade inflammation, as seen with
increases in TG, VLDL and IL-6 levels. Increased physical activity of ~12,500 steps/day
ameliorated these effects in as little as two weeks. Additionally, a high fructose diet when
consumed during a low physically active lifestyle altered insulin secretion while high physical
activity conferred protection by improving insulin secretion. This study also demonstrated that
these changes in insulin levels with high physical activity are possibly mediated by changes in
the incretin response. Taken together, our investigation supports previous research indicating that
chronic consumption of fructose increases postprandial lipidemia, low-grade inflammation and
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alters glycemic control. Our study showed that a highly physically active lifestyle alters the
susceptibility to cardiovascular risk factors and metabolic syndrome.
II. Strengths
There were several strengths to the current investigation. First, many nutritional
intervention studies tightly control the subject’s diet, making the results less clinically relevant.
In the current investigation, the subjects were instructed to eat their normal diets while only
limiting their consumption of sugar-sweetened beverages and sweetened desserts, allowing the
results to provide a better understanding of the consequences of the American diet. Additionally,
the fact that the subjects maintained body weight throughout the intervention, with little variation
in the macronutrient consumption of the diets, allowed us to determine the effects of physical
inactivity during a period of fructose loading without the confounding factor of weight gain. In
previous studies 49, 51, weight confounded the results.
Secondly, numerous studies 19, 49, 51 have measured the lipidemic effect of excessive doses
of fructose up to 200 g of fructose/day. These values do not correspond to the average U.S daily
intake of added sugar (~65 g/day), whereas our investigation incorporated a more realistic dose
of 75 g/day of added fructose. Lastly, most of the metabolic markers investigated previously
were measured under fasting conditions 51, 205. Americans spend a majority of their waking time
in a postprandial state in which they consume fructose-rich food every 2-4 hours. Examining the
metabolic changes following a fructose load allows for the identification of the potential
consequences of consuming a high fructose diet.

III. Limitations:

106
There were a few limitations to this project that must be addressed. First, although the
sample size was comparable to previous research 39, 43, 47, a larger sample size may offset the
large subject variability we observed in the studied variables. Secondly, we studied healthy,
recreationally active adults who may have been more resistant to the fructose and activity level.
Potentially more deleterious findings may be seen with an older, and/or obese population.
Therefore, the ability to provide substantial dietary and lifestyle recommendations across
populations is limited. Lastly, insulin sensitivity was not directly measured, which limited the
ability to fully establish whether changes seen were due to peripheral glucose uptake or changes
in hepatic glucose output.

IV. Future Direction:
Future studies should include quantifying LPL activity to determine if reduced physical
activity is associated with changes in LPL activity. This would provide better evidence of
whether a reduction in physical activity (<4500 steps/day) altered the enzymatic activity of LPL
associated with increased TG uptake. Additional metabolic markers to measure would be the
inclusion of various adhesion molecules associated with inflammation such as E-selection, Pselection, monocyte chemo-attractant protein -1 to better understand the extent to which fructose
and inactivity alter low-grade inflammation and endothelial dysfunction as both are significant
risk factors associated with metabolic syndrome.
Various methodical alterations such as a direct measurement of fractional DNL as well as
insulin sensitivity via euglycemic-insulinemic clamp could be employed in order to determine
whether an increase in fructose consumption with increased physical activity will directly alter
insulin and glucose uptake as well as TG and VLDL formation. In conjunction with the
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aforementioned change, the addition of muscle biopsies to clarify changes in insulin cellsignaling pathways would provide better evidence that second messengers associated with
insulin signaling are being altered as a result of increased fuctose-induced ectopic fats.
Changes in study design in which longer test days are utilized with more test meals, such
as those incorporated by Stanhope et al 47 and Parks et al 51, would provide more specific details
of the postprandial effects of a high fructose test meal. Secondly, using an obese population may
allow one the determination of whether various populations may be effected differently than the
healthy, recreationally active individuals used in the present study. Thirdly, comparing a subject
group in which they participated in the required 30-60 min of moderate exercise, 3-5 times/week
to a group that was physically active all day (>12,000 steps/day) to determine whether being
physically active has the same benefit as exercising most days of the week. Frequently,
individuals will exercise for 45 minutes/day but are sedentary the rest of the day. This design
would allow for comparison of structured exercise to daily physical activity on these
cardiovascular and metabolic risk factors. Lastly, the addition of a control group such as glucose
and/or water would allow the researcher to better determine whether the metabolic and hormonal
alterations were caused by the fructose ingestion or alterations in physical activity.
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Appendix
Items included:
1. Informed Consent
2. Institutional Review Board Approval Letter
3. Physical Activity
4. Health History Questionnaire
5. Dietary Logs
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Appendix 3
Physical Activity Questionnaire
NAME:________________________________
DATE:____________________
1. During the last 7 days, on how many days did you do vigorous physical activities like
heavy lifting, digging, aerobics, or fast bicycling,?
Think about only those physical activities that you did for at least 10 minutes at a time.
________ days per week or ___________ None
1b. How much time in total did you usually spend on one of those days doing
vigorous physical activities?
_____ hours ______ minutes
2. Again, think only about those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do moderate physical activities
like carrying light loads, bicycling at a regular pace, or doubles tennis? Do not include
walking.
days per week or ________________none
2b. How much time in total did you usually spend on one of those days doing
moderate physical activities?
_____ hours ______ minutes
3. During the last 7 days, on how many days did you walk for at least 10 minutes at a time?
This includes walking at work and at home, walking to travel from place to place, and
any other walking that you did solely for recreation, sport, exercise or leisure.
________Days
3a. How much time in total did you usually spend walking on one of those
_____ hours ______ minutes

days?
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Appendix 5
Dietary Food Record
Department of Exercise Science
Instructions:
• Fill in as much detail as you can regarding the food and drink that you consumed on these
particular days
• The dietary record table is divided into three sessions: Morning, Afternoon and Evening
• Please record all the food and drinks you consume, including any snacks that you had
between meals.
• The table has a column where you can write the quantity of food and the food description
• The quantity of food:
o In this section please provide as much information as possible regarding the
quantity of food
o You do not need to weigh the food necessarily, but if you can provide some sort
of measure (1 tablespoon of oil; 1 medium sized apple; 1 handful of nuts)
o If packaged, the serving information will be available on the package
• Food Description:
o In this section please provide information regarding the food type
o Try to be as specific as possible, for instance:
! Brown Rice; White Rice; long grain rice
! Potato Crisps-include the manufacturer and flavor
! Normal spaghetti noodles; Whole-meal spaghetti noodles
! Low-fat Ice cream (manufacturer)
! Yoghurt (manufacturer)
! Juice (manufacturer); high calcium; low sugar
These are just some examples related to the completion of the dietary record. If you have any
questions related to completing this sheet please do not hesitate to contact Amy on:
Email: ajsauve@syr.edu
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Some helpful serving size comparisons:
1. 3 ounces of meat is about the size and thickness of a deck of playing cards or a cassette
tape.

2. A medium apple or peach is about the size of a tennis ball.

3. 1 ounce of cheese is about the size of 4 stacked dice.

4. ½ cup of ice cream is about the size of a tennis ball.

5. 1 cup of mashed potatoes or broccoli is about the size of you fist.

6. 1 teaspoon of butter or peanut butter is about the size of the tip of your thumb.

7. 1 ounce of nuts or small candies equals one handful.
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Dietary Food Record
Department of Exercise Science

Other

Evening

Afternoon

Morning

Day One: _______________________________

Quantity

Food Description

____________
____________
____________
____________
____________
____________
____________

__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________

____________
____________
____________
____________
____________
____________
____________

__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________

____________
____________
____________
____________
____________
____________
____________

__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________
__________________________________________

____________ __________________________________________
____________ __________________________________________
____________ __________________________________________
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